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ABSTRACT
Membrane proteins are biologically significant targets of study due to their crucial roles in
biochemical reactions, such as ion transport and cell signaling. Their study, however, is
hampered by hydrophobic regions in their structures which cause aggregation without the
presence of a membrane. For this reason, solubilization systems have been developed, but
there are limitations to most. Nanodiscs were developed as an alternative platform that
provides a native-like lipid bilayer for solubilizing membrane proteins with unparalleled
control over lipid composition, exceptional monodispersity, and exceptional modularity.
This dissertation details the coupling of Nanodiscs to multiple analytical platforms for the
characterization of membrane systems, including Cytochrome P450s, blood coagulation
factor proteins, and other membrane protein targets. The topology of three different
Cytochrome P450 systems was characterized using linear dichroism spectroscopy. Methods
were developed for the coupling of Nanodiscs to two different types of photonic biosensors,
in atmospheric pressure and high pressure environments. The work further details the
development of a microfluidic platform for the optimization of membrane protein
incorporation into Nanodiscs as well as the development of a bimodal imaging construct
utilizing Nanodiscs and a Gd(III) chelating molecule used as a contrast agent for the
labeling of cells.
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CHAPTER 1
INTRODUCTION
1.1 Membrane Proteins
Membrane proteins are a common class of proteins present in all organisms, along with
soluble proteins, fibrous proteins, and disordered proteins.[1] It is estimated that 20-30% of
the genes in most genomes encode membrane proteins[2] yet membrane proteins make up
over 50% of the targets for currently available drugs.[3] Membrane proteins are responsible
for a variety of biological functions including transport, signaling, catalysis, and energy
conversion.[4] The membrane protein class is further divided into three different
sub-classes, based on the topology in the membrane: integral membrane proteins,
peripheral membrane proteins, and pore-forming toxins.[5] These proteins interact with the
membrane in different ways, ranging from being fully embedded in the membrane for
integral membrane proteins to temporarily interacting with the membrane in a
non-covalent manner and then dissociating for peripheral membrane proteins. The
membrane with which these proteins interact is an active and dynamic structure which
regulates the function and the biochemistry of membrane proteins.
Despite the fact that membrane proteins are biologically significant, studies with
traditional biochemical and analytical methods has proven challenging at best for several
reasons. Primarily, membrane proteins are often poorly soluble in the aqueous buffers
which are common in such methods. This is due to the fact that the proteins usually
contain a hydrophobic residue region in order to associate with the hydrophobic cellular
membrane. This can manifest as a full transmembrane region, such as a helix bundle or a
beta barrel, or a region on the surface of the tertiary and quaternary protein structure
which interacts with the membrane through a combination of hydrophobic and
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electrostatic interactions. Membrane proteins tend to aggregate and lose activity in the
absence of a membrane, rendering typical analytical methods useless without a strategy in
which to solubilize the analyte.
Second, membrane proteins are usually expressed at low levels throughout the natural
proteome of organisms and their recombinant overexpression in host cells is often
difficult.[6] When the proteins are overexpressed in host cells, they are usually toxic to the
host, express at lower levels than their soluble counterparts, and are often times misfolded
and therefore inactive.[7, 8] This means that there is a limitation on active materials
available for analysis and the small quantities available tend to be unstable for longer
periods of time.[9] This inherently prioritizes analytical methods which have minimal
sample volume requirements as the methods of choice in the study of membrane proteins.
Additionally, method optimization is a required step which usually takes the form of serial
trials and adjustments, increasing the requirement for materials. These considerations
often preclude the study of membrane proteins that express at levels too low to be useful
in analytical studies.
Finally, the interactions between the protein and the membrane are not negligible.
Protein activity can be modulated by a number of factors, including membrane charge,
membrane lipid composition, and even membrane thickness.[5, 10, 11, 12] Anionic lipids
have been shown to aid in the insertion of Cytochrome P450’s (CYPs) into the membrane
and to facilitate the electron transfer between enzymes.[13] Additionally, the
membrane-embedded domain of the protein can vary in length and structure, further
complicating the picture. As discussed, the membrane bound region can take the form of a
single helix, multiple helices, or even a barrel shape.[5, 14] This will can influence the
depth of insertion of the protein as well as the topology inside the lipid bilayer. Another
component of consideration when studying membrane proteins is that they are known for
being intrinsically unstable and quickly degrading.[9] This characteristic necessitates the
use of analytical techniques that are quick. While these issues have surely slowed down the
study of these targets, efforts have gone into developing membrane mimetic systems and
coupling them to established analytical methods in order to solubilize the target proteins
and enable the elucidation of their underlying mechanisms.
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1.2 Strategies Addressing Membrane Protein Solubilization
1.2.1 Detergent Micelles
One of the most common methods of solubilizing membrane proteins for analytical study is
by using amphipathic detergents. By utilizing detergents, the protein is extracted from the
natural membrane and encased in a micelle which provides a hydrophobic region for the
protein to reside in and is still soluble in aqueous environments. There are multiple types
of detergents which can be used for different biological systems, with optimized paramaters
available for most. The detergents are categorized in several classes: nonionic, anionic,
cationic, and zwitterionic, based on how they behave in solution. While these molecules
are enabling in membrane protein studies and are very effective at solubilizing membrane
proteins, caution must be exercised in order to prevent the detergents from denaturing the
protein of interest. If the protein is denatured, as is the case with some detergents, the
activity is lost and any experimemts are rendered moot. Additionally, there is not a single,
all-encompassing detergent that can be used to effectively solubilize all systems.[15, 16, 17]
This means that more material is used up in optimizing the detergent conditions of the
system, as the process can take time and materials spent in serial iterations of trial and
error.[6] Finally, detergents are intrinsically not representative of the natural lipid bilayer
environment that membrane proteins require. The composition of the membrane can
influence the activity of the protein therefore the ideal situation is that the protein remain
in a lipid environment during the analytical studies.
1.2.2 Liposomes and Lipid Vesicles
An alternative to strategy for the solubilization of membrane proteins is the use of
liposomes. Liposomes are bilayer lipid vesicles composed of one or more species of lipids.
The membrane proteins are incorporated into liposomes by first solubilizing the proteins
using a detergent and then removing the detergent either by dialysis or by hydrophobic
detergent removal beads.[18, 19] This method causes the lipids to assemble into vesicles,
incorporating the target membrane proteins in the process, due to hydrophobic
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interactions. However, while liposomes do present a more native environment than
detergent micelles for the membrane proteins, they also present several drawbacks. One of
the primary concerns is that liposomes are polydisperse in size. Their sizes can vary widely
and this doesn’t allow for very precise control of stoichiometry. The lack of control means
that multiple protein molecules are often incorporated into one vesicle and it is difficult to
study monomeric forms of multimeric species. Furthermore, liposomes have a limited
control of lipid composition, with data suggesting that lipid rafts often form within the
membrane of the liposomes.[20] Additionally, liposomes do not allow access to both sides of
transmembrane proteins. This property has been taken advantage of in some experiments
involving transporter proteins.[21] However, extra work is required when studying signaling
cascades which involve activating or monitoring both sides of transmembrane proteins.
While liposomes have been commonly used in the study of membrane proteins, the issues
outlined above render them unsuitable for some analytical techniques.
1.2.3 Lipoprotein Particles
Naturally occurring lipoprotein particles, such as high-density lipoprotein (HDL) particles,
form discoidal structures that consist of a lipid bilayer, encircled by an alpha-helical
amphipathic protein. Specially, in HDL particles, the encircling protein is Apolipoprotein
A-I (ApoAI).[22, 23] A self assembly process can be initiated by introducing detergent
solubilized lipids and ApoAI in a solution and proceeding to remove the detergent, forming
reconstituted HDL (rHDL) particles.[24] If a membrane protein is introduced into the
reconstitution mixture, the protein may preferentially assemble into the lipid bilayer and
be in a soluble, native-like environment, facilitating the application of analytical
techniques.[25] Additionally, other lipoproteins yield similar particles that can be used in
the analysis of membrane proteins.[26] Nanodiscs, particles of the lipoprotein class derived
from a genetically engineered ApoAI, have recently been growing in popularity among
researchers for the many advantages over other solubilization systems.[27, 28, 29]
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1.3 Nanodiscs
1.3.1 Nanodisc Development and Characterization
Nanodiscs are lipoprotein particles a discoidal lipid bilayer encircled by two amphipathic
helical proteins, termed the Membrane Scaffold Protein (MSP). MSP is derived from the
human ApoAI sequence, developed by the Sligar group in 2002.[30] The ApoAI sequence
was truncated in order to remove the globular N-terminal domain and further optimized
for expression in Escherichia coli (E. coli). As described in Section 1.2.3, Nanodiscs follow
a similar protocol of self assembly to rHDL particles by initially solubilizing components in
detergent and then removing the detergent from the mixture. The lipid molecules
self-arrange into a bilayer and the boundaries of the bilayer are stabilized by the MSP as it
shields hydrophobic regions from the aqueous solvent environment. The Nanodiscs retain a
hydrophilic surface due to the lipid head groups and residues on the MSP and remain
soluble in aqueous buffers while offering an environment for the incorporation of
hydrophobic molecules, such as membrane proteins.
The first MSP variant, termed MSP1, had 43 N-terminal residues removed from the
original ApoAI sequence, contained a hexa-histidne tag used for purification, and a Factor
X cleavage site on the N-terminal. A genetic fusion of two MSP1 molecules yielded the
construct MSP2, which could avoid the need for biomolecular assembly.[30] Additional
engineering of the protein found that the first 11 residues of MSP1 do not interact with the
lipid bilayer and could be truncated. The truncation of these 11 residues and the addition
of a tobacco etch virus (TEV) protease site between the hexa-histidine tag and the rest of
the sequence yielded the MSP1D1 construct, currently the most common and widely used
construct.[31] MSP has further been engineered by adding one or more 22-residue
amphipathic helices.[28, 31] The additions of these helices have allowed for the creation of
larger Nanodiscs, accommodating larger membrane proteins, oligomers, or multi-protein
assemblies.
Nanodiscs have been characterized by a variety of methods, including atomic force
microscopy (AFM), size exclusion chromatography (SEC), small angle X-Ray scattering
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(SAXS) and native mass spectrometry (MS). Nanodiscs made with the MSP1D1 variant
have been shown to be discoidal with a diameter of 10 nm and a thickness of 5-6
nm.[27, 31, 32, 33] The size of Nanodiscs has beeen further confirmed using SAXS, showing
a discoidal shape with a diameter of 10 nm.[31, 34] Scintillation counting methods utilizing
radiolabled lipids have been used to determine the average number lipids per Nanodic.[30]
Furthermore, native MS has shown that Nanodiscs are very monodisperse, with the
number of lipid molecules in each disc varying by 2-3 molecules per lealflet.[33] All of these
methods have proven to be consistent and show a specific ratio of lipids to MSP for each
species of lipids and MSP and a highly monodisperse construct with a defnied size.
Additionally, a number of membrane proteins have been shown to incorporate into
Nanodiscs. Similar to the process of incorporating membrane proteins into rHDL particles,
the proteins are solubilized using detergent and included in a reconstitution mixture
consisting of lipids, MSP, and target protein. The removal of detergent by dialysis or
hydrophobic beads facilitates a self assembly process which incorporates the membrane
protein in a native-like lipid bilayer.[28, 35] The hydrophobic region of the membrane
protein preferentially inserts into the lipid bilayer as the whole construct self-assembles.
The incorporated proteins remain properly folded and exhibit native activity levels while
incorporated into Nanodiscs.[31, 36] Nanodiscs have been used as the platform in multiple
studies involving membrane proteins because they offer several a series advantages over
other solubilization strategies, which will be outlined in the next section.
1.3.2 Nanodisc Advantages and Analytical Applications
The primary advantage of Nanodiscs is that they provide a native-like lipid bilayer
environment for membrane proteins. This means that the membrane proteins experience
an environment which is congruent to their physiological environment - a lipid bilayer,
without the presence of detergents, and solubilized in an aqueous biological buffer. The
lipid bilayer has been shown to to provide the environment for a better stability than
detergent micelles. Epidermal growth factor receptor (EGFR) has shown significantly
better stability in Nanodiscs when compared to detergent micelles.[37] Additionally, the
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lipid-bilayer of Nanodiscs preserves the native conformation and ligand binding activity.
The glycoprotein Ib-IX (GPIb-IX) complex, which is expressed on platelet plasma
membranes and is involved in thrombosis and hemostasis was shown to adopt a native-like
conformation and exhibit the ability to bind its natural ligands.[38] Furthermore,
Nanodiscs offer a detergent-free environment for proteins that eliminates any of the
detrimental effects of detergents. One example is that detergents can alter the binding of
substrates to cytochrome P450 3A4 (CYP3A4). The incorporation of CYP3A4 into
Nanodiscs allows for a characterization of activity, as well as a biophysical characterization,
which is addressed in detail in Chapter 2.[39, 40, 41]
Nanodiscs additionally allow for a very precise control of stoichiometry of all components
of the system - lipids, MSP, and target membrane protein. The surrounding lipid
composition has been shown to affect the activity of embedded membrane proteins. One
example of this is demonstrated through the lipid composition controlling the redox
potential of membrane bound cytochrome P450 proteins.[10] Furthermore, it is known that
lipid composition of the membrane can affect biophysical parameters such as binding to
the membrane, as shown by blood coagulation factors binding tighter to charged lipids in
comparison to uncharged lipids.[29, 42, 43] In order to be able to study these processes, the
lipid composition of Nanodiscs can be exactly defined in the reconstitution mixture. The
lipid content of the Nanodiscs can be modified and tailored to include conjugated lipids or
even lipophilic molecules for analytical and therapeutic purposes as will be further detailed
in Chapter 6.[44, 45] The stoichiometric control further extends to controlling the
oligomeric state of embedded proteins. Nanodiscs were used to directly prove the
physico-chemical and functional properties of monomers of bacteriorhodopsin, a protein
which is found to prefer a multimeric structure in vivo.[36, 46] This study proves the
ability of Nanodiscs to allow for control over the oligomeric states of target proteins.
The enabling properties of Nanodiscs require the coupling to analytical instruments in
order to elucidate membrane protein mechanisms. Nanodiscs have been shown interface
with a multitude of analytical techniques due to the fact that the MSP can be modified by
attaching or engineering a variety of tags. These tags include epitope tags, fluorescent tags,
and even using chemical crosslinkers to attach single stranded DNA (ssDNA), as will be
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addressed in detail in Chapter 4. The advantage of modifying the MSP on the Nanodisc is
that there is no need for modifying the membrane protein of interest, thereby eliminating
the chance for altering the activity or structure of the target protein. The tags can be
either genetically engineered so that they are expressed within the protein sequence, as has
been shown for polyhistidine, FLAG, and other affinity tags[28], or they can be added
chemically after expression. The chemical modification is achieved through two possible
pathways - lysine residues on the MSP can be used as reactive amine residues, or a set of
mutants of MSP1D1 which contain single point cysteine residue mutations can be used as
reactive thiol residues. Labels using either N-Hydroxysuccinimide (NHS) ester or
maleimide chemistry can be used to modify the MSP with fluorophores, targeting groups,
or for surface immobilization.
1.4 Applications of Nanodiscs to Biochemical Problems
1.4.1 Microscopic and Spectroscopic Characterization of Membrane
Proteins
Nanodiscs have been gaining ground as a platform used in structural biology techniques.
Even though efforts in crystallizing the entire Nanodisc-protein complex for X-Ray
crystallography have so far proven to be unsuccessful, Nanodiscs have been used in other
imaging methods, such as AFM[27, 30, 36] and electron microscopy (EM)[35, 47, 48, 49] to
obtain low resolution structures of membrane proteins as well as topological information
about the membrane. In order to gain more structural information, Nanodiscs have been
applied to a number of NMR studies[50, 51, 52, 53] as well as a variety of mass
spectrometry (MS) studies.[33, 54, 55, 56] Additionally, Nanodiscs have been used with
with spectroscopic studies because of their low scattering. Studies utilizing
absorbance[36, 39, 57, 58], fluorescence[59, 60, 61], and Raman[62, 63] spectroscopy for
membrane protein structure and function have utilized Nanodiscs as the platform.
Nanodiscs were used in conjunction with resonance Raman spectroscopy to gain insights
into the catalytic cycle of the membrane bound cytochrome P450 17A1 (CYP17) and
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cytochrome P450 19A1 (CYP19) proteins.[62, 63] Of interest, recent efforts have gone into
further engineering the MSP to exclude the aromatic tryptophan and tyrosine residues in
order to minimize the optical fluorescence background present in Nanodiscs for the use of
label-free fluorescence studies.
1.4.2 Biosensors Surface Plasmon Resonance and Silicon Photonic
Resonators
Nanodiscs are a powerful technology for creating a well-defined cell membrane mimetic,
but they are only part of the solution of investigating bilayer surface interactions.
Biosensors have been have recently been at the forefront of the study and characterization
of biomolecular interactions. These sensors are designed to have high sensitivity and to
utilize label free techniques in order to eliminate any chance of altering the activity or
structure of the biological analyte. Surface plasmon resonance (SPR) has been one of the
widely used techniques to study the biomolecular interactions of membrane proteins with
lipids, small molecules, or even soluble proteins.[64, 65] With SPR, an analyte is
immobilized on the surface of a gold-coated sensor and a ligand is flowed over the surface
of the chip, monitoring the change in refractive index on the surface as the ligand interacts
with the immobilized surface. Nanodiscs have simplified the immobilization procedure by
providing a polyhistidine tag on the N-terminal which can be immobilized to a Ni-chelating
surface on the SPR chip. For example, polyhistidine tagged Nanodiscs containing different
concentrations of phosphatidylserine (PS) were attached to a Ni-NTA modified surface
chip to measure the binding affinity of Factor X to PS.[29] In a separate example,
Nanodiscs were immoblized to chip using an anti-tetra-His antibody on the flow cell.
Nanodiscs which contained GM1 were immoblized while a solution of CTB was flowed over
the chip and the binding was monitored.[66] What this means is that the protein of
interest can remain unlabeled, while the label used for attachment is placed on the
Nanodisc, keeping the analyte completely unmodified.
Similar to SPR, silicon photonic resonators devices are an evanescent wave sensor that
monitors the change in refractive index of the surface attached analyte. It is known that
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phospholipid systems adsorb to silicon surfaces when there are divalent cations present in
the solution.[30, 67] Nanodiscs are similar in that respect to other phospholipid containing
systems, having the ability to directly physisorb to silicon oxide surfaces, such as those in
microring resonator biosensors. In a previously published study, Nanodiscs were adsorbed
to silicon photonic microring resonators employing this strategy.[68] There were four species
of Nanodiscs Nanodiscs containing 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine
(POPS) lipids, Nanodiscs containing biotinylated lipids, Nanodiscs containing ganglioside
glycolipid GM1 (GM1), and Nanodiscs containing CYP3A4. The specific substrate of each
species was flowed over a single chip which had all 4 species immobilized on the surface and
a specific response was observed for each analyte. This study demonstrated that Nanodiscs
could be interfaced with these resonator biosensors in a simple physisorption fashion but at
the same time exhibit specificity as well as multiplicity on the same sensor chip.
1.4.3 Therapeutic Delivery Agents
Nanodiscs are analogous to re-engineered rHDL particles in that they are biocompatible
and antigenically neutral. Therefore, Nanodiscs can be considered as a viable option for
therapeutic agent delivery in vivo. Liposomes have long been considered to be a leader in
drug delivery agents for lipohilic molecules.[69, 70, 71] However, there are a lot of issues
that arise from using liposomes, including those of heterogeneity, shelf-life, and stability in
vivo. Liposomes can aggregate and fuse together, decreasing the efficacy of the delivery.
Nanodiscs, on the other hand, have the advantages of having precise control of lipid
composition, having homogeneous size, and stability during lyophilization and
reconstitution.[45] Furthermore, Nanodiscs are much smaller than liposomes, having the
ability to transport faster and more efficiently. A previously published study showed the
utility of Nanodiscs used as carriers for therapeutic compounds. Nanodiscs containing
1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1’-rac-glycerol) (POPG) lipids were used as
therapeutic delivery agents against respiratory syncytial virus (RSV) in both in vitro and
in vivo models. The lipids act as a surfactant and inhibit the binding of the virus to
epithelial cells. The virus was found to be attenuated by the delivered lipids in both models
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and the potency and effectiveness was evaluated. Nanodiscs were found to be effective in
inhibiting RSV and thus a viable delivery option. This is the first work to show Nanodiscs
being used as a delivery agent for therapeutic compounds and suggested that Nanodiscs
can be further developed for the delivery of other lipophilic, therapeutic molecules.
1.4.4 Microfluidic Devices
Microfluidic devices are an attractive option when it comes to developing high throughput
assays which involve the precise patterning of molecules of interest on a surface. The
microfluidic technique has been applied to immunoassays[72] as well as protein analysis.[73]
The advantages of using microfluidic platforms was also extended to Nanodiscs.[67] Using
microfluidic channels patterned on a poly(dimethylsulfoxane) (PDMS) chip, Nanodiscs of
different lipid compositions were patterned on a glass surface with precise spatial control.
This work used two different systems, first a population of Nanodiscs with biotinylated
lipids and streptaviidn, and the second system using PS lipids and annexin. The second
population of Nanodiscs created a high density assay of Nanodiscs for the measurement of
binding kinetics of annexin to various PS compositions. The patterning of Nanodiscs was
evaluated using AFM to verify the generation of a tightly packed monolayer. The results
showed that Nanodiscs could be coupled with microfluidic devices in order to create high
throughput, multiplexed sensor devices. Taking a step forward from using microfluidic
devices for patterning, Zahi Fayad and coworkers showed a system able to reconstitute
rHDL particles in a microfluidic device.[74] The system employed in that study showed the
assembly of lipoprotein particles, with hydrophobic molecules or quantum dots embedded
within the lipid bilayer. This shows that methods which facilitate the assembly and use of
well controlled lipid bilayer particles are being developed as an alternative to current
standards, such as liposomes. Nanodiscs are well suited for being assembled on a
microfluidic device due to the simplicity of the self assembly process. The required
components - lipids, MSP, and a target membrane protein - are first solubilized in
detergent and mixed together. The detergent is then removed to facilitate the self assembly
process. Implementing the process on a microfluidic scale can exhibit multiple advantages
11
over traditional methods, such as a decrease in time of assembly and a decrease in sample
volume requirements.
1.4.5 Dissertation Outline
The main focus of this dissertation is the application of the Nanodisc platform to a variety
of analytical methods and techniques in order to gain a deeper understanding of
biophysical processes as well as to develop methods for clinical applications. These topics
include the study of the topology of membrane proteins inside the lipid bilayer, developing
a high throughput biosensor array for diagnostics, developing magnetic resonance imaging
(MRI) contrast agents, and exploring the assembly of Nanodiscs on a microfluidic
platform. The work represents advancements in the understanding of crucial mechanisms
behind protein-protein and protein-lipid interactions. It goes on to suggest future studies
to build upon the platforms developed here.
Chapter 2 details the study of the orientation of CYPs incorporated into Nanodiscs.
Three biologically significant enzymes are explored in this chapter. These enzymes are
responsible for the metabolism of over half of the therapeutic compounds currently
available as well as having a major role in the steroidogenesis pathways.[58, 75] However,
there have been no crystal structures of these proteins within the lipid bilayer and the
mechanism of substrate entry into the active site is not well understood. The chapter
describes the building of an instrument which uses total internal reflection (TIR) in
combination with linear dichroism (LD) in order to probe the orientation of the absorbing
heme cofactor which is located in the active site of CYPs. This experimental study was
coupled with a modeling study that gave insights into the topology of the enzymes and
their substrate access channels.
Chapter 3 describes the development of a high pressure biosensor platform for the study
of biomolecular recognition events. The system is based on a label free retroreflective
biomolecular sensor, the BIND assay, which was developed by Brian Cunningham and
coworkers.[76, 77] The assay is deployed in a high pressure bomb and a series of
experiments show its utility in probing biological systems using hydrostatic pressure. The
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system was validated using a series of salt solutions at different concentrations and
pressures. The compressibility of each solution was calculated and compared to published
values. The system can be used to monitor molecular interactions, as the peak wavelength
shifts with a change in refractive index. Furthermore the biosensor is well suited to be
implemented under high pressure because it does not require any specialized optics, which
could shift under pressure.
Chapter 4 discusses the development of a multiplexed high throughput biosensor
utilizing Nanodiscs and photonic waveguide microring resonator biosensors. Nanodiscs
were immobilized using complementary single stranded DNA (ssDNA) labels. This chapter
details the development of a method to label Nanodiscs with ssDNA and take advantage of
complementary base pair recognition in order to immobilize Nanodiscs of different lipid
composition on a single microring resonator chip. A single sensor with multiple
populations of Nanodiscs can be used in a high throughput kinetic study of membrane
protein interactions with minimal sample requirements. The studies in this chapter extend
the previously published work which established the combination of the two novel
technologies in order to create a highly multiplexed system for elucidating protein:lipid and
protein:protein interactions in a high-throughput fashion.
Chapter 5 explains in detail the design and development of a microfluidic device used for
assembling Nanodiscs in a quick and facile manner. This chapter addresses the specific
issue of having small amounts of material when it comes to using and analysing membrane
proteins. Using microfluidic devices, membrane protein incorporation into Nanodiscs can
be accomplished quickly and use less materials than traditional methods. This is
demonstrated by incorporating CYP3A4 into Nanodiscs. A gradient method of
optimization is demonstrated, using less materials than traditional optimization studies.
Additionally, this method enables the parallel screening of multiple detergents when
optimizing the incorporation of a membrane protein. This in turn enables the optimization
of membrane protein incorporation with a reduced requirement for reagent materials, a
process that is often costly in both time and materials.
Chapter 6 addresses the development of a Nanodisc-based system for the incorporation
and delivery of Gd(III) chelate MRI contrast agents. Lipophilic Gd(III) chelate molecules
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were previously synthesized and used as MRI contrast agents in vitro. In this work, two
lipophilic contrast molecules were incorporated into fluorophore labeled-Nanodiscs. The
Nanodisc assembly was used as an imaging platform for labeling and tracking cells both
optically and using MRI, exploiting the high modularity of the Nanodisc platform. The
chapter details cell tracking studies, localization studies, as well as contrast enhancement
studies. The system represents the first example in literature of using Nanodiscs for the
delivery of imaging contrast agents.
Chapter 7 summarizes each of the individual chapters and suggests further experiments
to be conducted in order to continue the work on biophysical characterization of membrane
proteins, further applications of the biosensor systems, and continued work on the
therapeutic delivery agents.
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CHAPTER 2
ORIENTATION OF CYTOCHROME P450S WITHIN
THE LIPID BILAYER
2.1 Introduction
Cytochrome P450s (CYPs) are a superfamily of heme-containing isoenzymes that are
present in all organisms. CYPs are responsible the metabolism of external therapeutic
compounds as well as the biosyntehsis of endogenous compounds via oxidation.[58] The
enzymes are present in organisms in both soluble as well as membrane bound form and
they are able to oxidize both hydrophilic as well as lipophilic molecules. A number of
crystal structures have been solved for CYPs, both in their apo as well as substrate-bound
form, but to date no crystal structure has been solved of a full length, membrane-bound
form.[78] Human CYPs are comprised of a globular domain, which sits above the
membrane, as well as an N-terminal alpha helix, which anchors the enzyme into the
membrane. A large body of evidence suggests that the globular domain interacts with the
lipid bilayer, which in turn raises the question of how substrates enter and exit the active
site.[79] A school of thought suggests that the route of entry of lipophilic substrates into
the active site is primarily through the membrane.[80, 81] However, the mechanism of
substrate entry is not entirely understood and the topology of CYPs within the lipid
bilayer requires further characterization.
The most abundant isoform in humans, cytochrome P450 3A4 (CYP3A4), is responsible
for the metabolism of over 50% of the currently available clinical drugs.[82] Other isoforms,
such as cytochrome P450 17A1 (CYP17) and aromatase cytochrome P450 (CYP19) are
Reproduced in part with permission from Baylon, J.L.; Lenov, I.L.; Sligar, S.G.; and Tajkhorshid, E.
Characterizing the Membrane-Bound State of Cytochrome P450 3A4: Structure, Depth of Insertion, and
Orientation J. Am. Chem. Soc. 2013 135 (23), 85428551 Copyright 2013 American Chemical Society. The
published version may be found online at http://pubs.acs.org/doi/abs/10.1021/ja4003525.
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responsible for the synthesis of endogenous hormones.[83, 84] These enzymes can be found
in the liver and small intestine for CYP3A4 and in the gonads and adipose tissue for
CYP17 and CYP19.[75] The enzymes are primarily localized in the endoplasmic reticulum
within the cell. The solved crystal structures of all three proteins have suggested that they
present overall tertiary folds which are similar to one another as well as other CYPs,
consisting of an N-terminal -sheet domain and a helical C-terminal domain, containing the
cofactor heme in the active site.[85, 86] However, the published crystal structures are all of
truncated forms, which exclude the N-terminal transmembrane helix as well as the
membrane itself. This leads to a lack of understanding of the topology of the enzymes in
the membrane and an explicit need for experimental data exploring this area.
Experiments have examined the interaction of multiple substrates and their homotropic
and heterotropic cooperativity has been explored for CYP3A4.[31, 41, 87] The studies
found that CYP3A4 has a very flexible active site and can accommodate up to three
substrate molecules[83], with the number of bound substrates modulating the activity of
the enzyme. Furthermore, the identity of the substrates can induce cooperativity, showing
a stimulatory effect on the activity of the enzyme for other substrates present. High
pressure studies have been conducted on the enzyme showing the enzyme displays
conformational heterogeneity.[88, 89] These studies showed that the activity of CYP3A4
can be modulated by the oligomeric state of the enzyme. The high-spin state of the
enzyme was observed to exhibit unusual stability under hydrostatic pressure, reflecting
decreased accessibility of water into the active site, and suggesting specific interactions
with the lipid bilayer.
In addition to crystal structures and catalytic activity experiments,the structural
dynamics have been explored by molecular dynamics (MD) simulations. There have been
multiple MD simulations which have explored how CYPs interact with a multitude of
substrates. For example, studies have focused on examining the hydration of the active site
and how that affects substrate binding.[90] Even further, active site gating has been
explored by MD simulations for CYP17 and CYP19.[91, 92] While these simulations
provide very useful information, they usually don’t account for the interactions with the
lipid bilayer. More recently, simulations have explored membrane interactions of CYPs,
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specifically exploring the topology of the enzymes within the membrane.[93, 94, 95]
Simulations have shown insights into the orientation of the enzymes but the results have
given rise to speculation as some show the protein adopting two orientations or even a
burial of the globular domain within the hydrophobic part of the lipid bilayer.
While MD simulations provide valuable information, there is still a need for experimental
studies exploring the topology of these biologically critical enzymes. In order to reveal the
topology of the protein in the phospholipid bilayer and gain an insight into the mechanism
of hydrophobic substrate entry, CYP3A4, CYP17, and CYP19 were expressed, purified,
and self-assembled into Nanodiscs of POPC lipid composition. A series of linear dichroism
measurements were carried out on a custom built instrument by first adsorbing the
Nanodisc-incorporated proteins onto a glass substrate and measuring heme absorbance
using two orthogonal polarizations of linearly polarized light. The angle of the heme plane
determines the relative orientation of the P450s with respect to the the laboratory z-axis,
and therefore the lipid bilayer. The data from this work shows that CYPs adopt a specific
structure and orientation within the lipid bilayer and do not adopt random orientations.
The heme orientations calculated with this method, along with the MD simulations, show
that the globular domain is responsible for interactions with the lipid bilayer and the
protein-lipid interaction is not solely dependent on the transmembrane helix of the
enzymes. These insights allow for a detailed description of the enzymes in their
membrane-bound form and a better understanding of substrate entry into the active site.
2.2 Methods
2.2.1 Theory
As light is incident upon an interface between two transparent media, it is partially
reflected as well as partially transmitted. However, light inside of an internal reflection
element (IRE) is totally internally reflected, having no transmitted element. The angle of
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reflection is known as the critical angle and is calculated by the following equation:
θc = sin
−1 n2
n1
(2.1)
where n2 and n1 are the refractive indices of medium 2 and medium 1, respectively. This is
a well-known phenomenon, which has been studied extensively.[96, 97] Using the ray-optics
approximation, it is known that an electric field, known as the evanescent field, penetrates
the surface of the rarer medium and decays exponentially with distance from the surface of
the medium. The electric field interacts with material close to the surface and has
amplitude of:
E = E0e
−γ2 (2.2)
The amplitude can be separated into components corresponding to the magnitudes of
the electric fields that extend along the laboratory axes, as given by the equations
formulated by Harrick[98]:
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n1
]2) 12
cos θi(
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n1
]2) 12 [(
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]2)
sin2 θi −
(
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)2] 12 (2.3)
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2 cos θi(
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Ez =
2 sin θi cos θi(
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]2) 12 [(
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n2
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sin2 θi −
(
n2
n1
)2] 12 (2.5)
where θi is the incident angle and n2 and n1 are the refractive indices of medium 2 and
medium 1, respectively. Knowing the electric field amplitudes along the laboratory axes, it
is possible to calculate the absorbance of a chromophore which is adsorbed to the surface
of the IRE. Cropek, et al. showed that the absorbance of the chromophore on the surface
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can be calculated by the following equation: [99]
A = c1
∣∣∣〈m ∣∣∣~µ · ~E∣∣∣ k〉∣∣∣2 (2.6)
where c1 is a constant, m and k are the states of the transition, ~µ is the absorption
transition moment, and ~E is the electric field vector. This equation can be further broken
down in terms of the laboratory axes:
A = kl (µxEx + µyEy + µzEz)
2 (2.7)
where k is a constant and l is an effective path length. Two approximations are made to
simplify the mathematical treatment. First, a heme ring can be approximated as a circular
oscillator which means that it has two orthogonal dipole transitions. The dipole transitions
are x,y polarized, and it follows that the two transition moments of the heme are
degenerate.[100, 101] Second, the molecules on the surface are not artificially ordered along
either the x or y axes and the samples are uniaxially symmetric. Applying this assumption
to the mathematical treatment, the absorbance can be simplified and broken down into the
three distinct components along the laboratory axes with the following three equations:
ATE =
1
2
kl |Ey|2 |µ|2 sin2 θ (2.8)
ATM,x =
1
2
kl |Ex|2 |µ|2 sin2 θ (2.9)
ATM,z =
1
2
kl |Ez|2 |µ|2 cos2 θ (2.10)
where θ, the orientation angle, is the angle between the transition moment and the
laboratory z-axis. The subscripts TE and TM refer to transverse electric polarized and
transverse magnetic polarized light, respectively. TE polarized light is oriented only in the
y direction and only absorbers with a transition moment component in the y direction will
absorb TE polarized light. TM polarized light is oriented in the x and z directions, thus
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only absorbers with transition moment components lying in the x or z direction will be
able to absorb TM polarized light. The ratio of the absorbance of TE to TM polarized
light, the dichroic ratio, can be used to determine the orientation of the absorber. The
following equation relates the dichroic ratio to the orientation angle of the absorber:
ρ =
ATE
ATM
=
|Ey|2
|Ex|2 + 2 |Ez|2 cot2 θ
(2.11)
where ρ is the dichroic ratio and is the angle between the transition moment vector and
the laboratory z-axis. Since all of the proteins in this study, CYP3A4, CYP17, and CYP19
are heme-containing enzymes, it is possible to take advantage of the heme as the absorber
and monitor the anisotropic absorbance of the Soret band in order to determine the
orientation of the heme with respect to the z-axis and hence, the protein in the lipid bilayer.
2.2.2 Materials and Apparatus
The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) were purchased from
Avanti Polar Lipids (Alabaster, AL, USA). The scaffold protein, MSP1D1 was expressed
and purified as described previously.[30, 31] CYP3A4 was expressed with a histidine
affinity tag from the NF-14 construct in the pCWOri+ vector, purified, and incorporated
into POPC Nanodisc lipid bilayers as previously described.[41, 83, 102, 103] Nanodiscs
containing purified CYP17 and CYP19 were generously provided by Ruchia Duggal,
Michael Gregory, and Dr. Abhinav Luthra. The Nanodiscs were stored in buffer before use
(50 mM Tris/HCl pH 7.4, 0.3 M NaCl). Sodium cholate, Amberlite XAD-2 hydrophobic
beads, and all other chemicals were purchased from Sigma Aldrich (St. Louis, MO, USA).
Buffers were prepared with 18 MΩ deionized water and filtered prior to use.
The diagram of the instrument is shown in Figure 2.1 while a picture of the actual
instrument is shown in Figure 2.2. A commercially available 405 nm laser diode was used
in the laser module. The laser spot was reduced using a pinhole and any stray polarization
was excluded by using a Glan-Taylor polarizer. The whole laser assembly, which includes
the laser, pinhole, and the polarizer, was mounted on a rotational stage to precisely select
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between TE and TM polarized light. The light was incident onto the slide assembly, which
is composed of the IRE, posts at the four corners, and a microscope slide underneath. The
solution was sandwiched between the IRE and a regular glass slide, separated by the four
corner posts. Two BK7 prisms (Edmund Optics, Barrington, NJ) were used to to couple
the light in and out of the IRE. The entire slide assembly was placed on a
custom-machined, temperature-controlled, aluminum slide holder. The IRE substrates
used were SuperClean 2 Microarray Substrates (Arrayit Corporation, Sunnyvale, CA) with
dimensions of 25 x 76 x 0.940 mm. The out-coupled light passed through a 405 nm band
pass filter and onto a light diffuser before being detected by a phototube (Newport Corp.,
Irvine, CA). The output of the phototube was amplified by a low noise current amplifier
(Stanford Research Systems, Sunnyvale, CA) and subsequently measured by a digital
multimeter (Hewlett Packard, Palo Alto, CA). The signal was averaged and recorded using
a program developed in the LabVIEW programming environment (National Instruments,
Austin, TX).
2.2.3 Experimental Procedure
In order to facilitate adsorption onto the substrate, MgCl2 was added to the buffer before
adding Nanodiscs to the substrate. The temperature of the slide holder was set to 20 ◦C. A
background signal was measured on the slide assembly using tris buffered saline (TBS)
buffer containing MgCl2. Subsequently, Nanodiscs with CYP protein incorporated were
added to the buffer on the substrate so that total concentration of CYP was 100 nM and
the total concentration of MgCl2 was 10 mM. The addition of Nanodiscs to the solution
forms a monolayer at the silicon surface between the substrate and the bulk solution, with
free Nanodiscs in the bulk solution. After incubating for 30 minutes, which is required for
adsorption to the glass, the substrate was flushed with 2 volumes of buffer to wash away
the free Nanodiscs. The final signal was measured and compared to the background signal
to calculate the monolayer absorbance. The same procedure is repeated for both
polarizations of light.
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2.3 Results and Discussion
Each CYP isoform had multiple measurements conducted on multiple glass substrates. A
total of 11 unique measurements were conducted for CYP3A4, which spanned three
different preparations of protein assembled into Nanodiscs. A total of 15 separate
measurements were conducted per enzyme for CYP17 and CYP19. Each sample was
measured on a separate and different glas substrate and the signal averaged until an
equilibrium was reached. The average orientation angle of the heme moiety in the 11
samples of CYP3A4 associated to Nanodiscs was 60 ± 4◦ with respect to the Z-axis.
(Table 2.1) The average orientation angle of the heme in the 15 samples of CYP17
associated to Nanodiscs was 64 ± 4◦ with respect to the Z-axis. (Table 2.2) The average
orientation angle of the heme in the 15 samples of CYP19 associated to Nanodiscs was 55
± 4◦ with respect to the Z-axis. (Table 2.3)
These measurements are in close agreement with previously published work, both
theoretical and experimental. Since CYP3A4 is responsible for the metabolism of over 50%
of clinically available therapeutic compounds, it has been the subject of a multitude of
studies. This experimental work was coupled with MD modeling work, employing a novel
highly mobile membrane mimetic model (HMMM) which reported the orientation of the
heme group to be 72◦.[40] The simulation was then extended to fill in the lipophilic tails of
the POPC lipid molecules so that the full length lipids are present in the bilayer. The
protein was subsequently allowed to equilibrate with the presence of the full lipid tails.
The results of the full length lipid simulation show that the heme of CYP3A4 lies at 57 ±
6◦ with respect to the Z-axis. These values are in very close agreement and show details of
the protein associating with the membrane bilayer which are not able to be determined
experimentally such as the position of the substrate access channels.
Additionally, other published studies report theoretical results for the orientation of
CYP3A4 which fall between 52◦ and 72◦.[93, 104, 105, 106] The orientation of CYP17 in
liposomes was determined using the method of rotational diffusion with a flash photolysis
depolarization apparatus, reporting either 47◦ or 63◦.[107] The calculation of the results
depends on a second-order polynomial, the solution of which yields the two possible values.
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The orientation of CYP17 has also been explored theoretically, with one study finding that
the protein equilibrates to two distinct orientations in the simulation, around 40◦ and
around 60◦.[94] A total of five simulations were conducted, each one starting at a unique
heme angle and allowed to equilibrate. Two of the simulations converged to 40◦ and three
of the simulations converged to 60◦ in 100 ns. Two simulations were extended to 150 ns,
and no large scale fluctuations were observed. Additionally, Rommie Amaro and coworkers
addressed the orientation of CYP19 using MD simulations, finding that the enzyme
equilibrates at an orientation of 57◦ with respect to the Z-axis.[95] Two different
structures, one with a protonated aspartate 309 and one with a deprotonated residue are
examined and the heme angle determined for both. The structures were allowed to
equilibrate for 250 ns and the values averaged.
2.4 Conclusions
Characterization of the membrane-bound form of CYP enzymes is crucial to the
understanding of the topology of the proteins as well as the mechanism of substrate entry.
Studies addressing these questions have employed simulations in the past, but few have
addressed these questions experimentally. This chapter described the work that addresses
the question through the use of Nanodiscs coupled with LD spectroscopy. The results show
that the three different enzymes used in this work adopt slightly different orientations
within the POPC lipid bilayer. However, each enzyme adopts a specific conformation
within the membrane and the average is reported. This information is used a step in the
direction of understanding the mechanism behind substrate access to the active site. The
results show that there are slight differences in the orientation of all three enzymes. That
would suggest that the interaction between the protein and the lipid bilayer are not merely
through the transmembrane helix, but also through protein lipid interactions in the
globular domain. Furthermore, the results would imply that the interactions are specific to
each enzyme and help orient its position within the bilayer.
Theoretical treatment of CYP3A4 accompanying the experimental work comes in close
agreement with the experimental values calculated using the LD method. (Figure 2.3) The
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simulations further show that the globular domain of the proteins interacts with the lipid
bilayer and suggest that the interaction is not merely nonspecific and based on proximity.
Rather, the interaction is through a set of specific protein-lipid interactions which
modulate the orientation the enzymes undertake when associated with the membrane. The
simulations further show that the association of the enzyme has an effect on the substrate
access channels, which cannot be seen in the crystal structures. Additionally, HMMM
simulation studies are currently being conducted on CYP17 and CYP19.
We show that membrane binding of three different CYP enzymes has significant
structural and dynamical impacts on its globular domain at the membrane interface. The
presence of the membrane induces a each enzyme to adopt a specific orientation, suggesting
that binding to the membrane might play a role in efficient recruitment of lipophilic ligands
from the membrane to the active site. The fact that the orientations are slightly different
for the three different enzymes prompts the question of how this orientation is controlled
on a molecular level. The topology of the enzymes could be controlled primarily by the
head group of the lipids. Since the globular domain interacts with the lipid bilayer it is
plausible that the charge on the lipid head group, and the specific lipid:protein interactions,
will affect how the protein orients itself. Furthermore, the length of the tail of the lipids
could be another key factor in this regard. Not only does the length affect how deep the
protein is embedded in the bilayer, but the length also dictates the transition temperature
of the bilayer. These questions prompt further exploration into the topic of CYP
orientation within the membrane and how affects the mechanism of substrate recruitment.
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2.5 Figures and Tables
Figure 2.1: A diagram of the home-built instrument LD instrument used. The laser,
polarizer, and pinhole are all mounted on the rotating stage. The notch filter, diffuser and
PMT are all located within the PMT housing. The signal is routed through the amplifier
into the DMM and then averaged and recorded by a LabVIEW program.
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Figure 2.2: A side and top-down view of the actual instrument used in these experiments.
The instrument was built based on the diagram above and it is all mounted on a laser
table. The rotating stage is controlled by a separate module and the slide stage is
controlled by hand using fine thread screws.
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Table 2.1: Orientation of Heme in CYP3A4
Trial Angle
1 61◦
2 58◦
3 58◦
4 61◦
5 59◦
6 52◦
7 60◦
8 56◦
9 63◦
10 67◦
11 63◦
AVG 60◦
Std.Dev. 4◦
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Table 2.2: Orientation of Heme in CYP17
Trial Angle
1 60◦
2 56◦
3 62◦
4 69◦
5 65◦
6 73◦
7 60◦
8 62◦
9 63◦
10 63◦
11 59◦
12 69◦
13 64◦
14 63◦
15 65◦
AVG 64◦
Std.Dev. 4◦
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Table 2.3: Orientation of Heme in CYP19
Trial Angle
1 48◦
2 56◦
3 57◦
4 49◦
5 52◦
6 49◦
7 59◦
8 51◦
9 63◦
10 50◦
11 59◦
12 58◦
13 57◦
14 58◦
15 56◦
AVG 55◦
Std.Dev. 4◦
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Figure 2.3: Trajectory traces of the heme orientation of five different simulations of
CYP3A4 using the HMMMM model. This figure shows that the orientation of CYP3A4
started out at 5 different values and converged to one value. The heme plane was defined
by fitting the position of the four porphyrin nitrogen atoms to a plane. The angle θ is
defined as the angle between the membrane normal (z-axis) and the heme plane.
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CHAPTER 3
DEVELOPMENT OF THE HIGH PRESSURE
LABEL FREE BIND ASSAY
3.1 Introduction
Hydrostatic pressure modulation has been previously used in conjunction with surface
plasmon resonance (SPR) and optical absorbance experiments to study the optical and
physical properties of polymers and solutions of bio-molecules.[108, 109, 110] An advantage
of SPR is the ability to observe biological interactions without the requirement of labels,
such as chromophores, which can alter the folding and activity of bio-molecules. The
technique is based on observing changes in refractive index and quantifying the change
based on a shift the peak wavelength.[64, 111] However, using SPR in the
Kretschmann[112] configuration requires the use of specialized optics, such as optical
prisms and focusing lenses.[111] Optics such as these are prone to shifting, expanding, and
contracting under hydrostatic pressure. Slight movements of the optics can cause a shift in
the angle of incidence as well as change the critical angle. Furthermore, subjecting optics
to external pressure can change the density of the optics, therefore changing the refractive
index of the optics. For these reasons, SPR cannot be considered an ideal method for
investigating pressure dependence and compressibility.
Ideally, an analytical method would not require complex coupling optics and would not
depend on a very specific angle of excitation. A recent push for the development of bedside
diagnostic tools has spurred the development of a multitude of optical biosensors.[113, 114]
These sensors detect a change in the optical density of the medium in contact with the
sensor, whether the change is caused by the binding of biological material or a change in
the bulk analytite solution. Developed by Brian Cunningham and coworkers in 2002[76, 77]
the Biomolecular INteraction Detection (BIND) Assay sensor utilizes a sub-wavelength
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grating as a waveguide structure. The sensor is illuminated with white light at normal
incidence using a fiber optic probe and a narrow band of resonant wavelengths is reflected
back. The reflected band of resonant wavelengths can be modulated by a change in the
dielectric constant of the material in contact with the grating - which is the result of an
attachment of molecules directly onto the surface of the sensor.[76, 115, 116] Unlike optical
detection approaches that rely upon interaction of detected molecules with an evanescent
wave, the detection in this sensor actually occurs within the waveguide. This is due to the
change of the optical path of the light that is coupled into the grating. A
spectrophotometer collects the reflected light through a second fiber, which is at normal
incidence to the sensor as well. As there is no physical contact between the readout system
and the grating surface, no coupling prisms are required.
A system that utilizes BIND Assay grating sensors inside of a high-pressure optical cell
used for measuring the pressure dependence of the refractive index of bulk solutions is
described in this chapter. Using the BIND Assay gratings in a pressurized environment is
possible since there is no need for coupling optics and the grating is both illuminated and
read at normal incidence. In this chapter, the BIND sensors are first mounted inside a
custom-made high pressure cuvette, which is filled with the analyte. The entire high
pressure cuvette assembly is then put inside a high pressure bomb before being pressurized.
The compressibility of several mixed, aqueous solutions is calculated using the BIND Assay
in conjunction with high pressure. The theory of both the sub-wavelength grating and the
use of hydrostatic pressure as a perturbant are first discussed, then the chapter describes
how pressurizing different concentrations of sodium chloride (NaCl), sucrose, and ethanol
affects the refractive index. These measurements allow for the calculation of
compressibility at varying pressures up to 21,000 psi. The system is further designed to
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3.2 Theory
3.2.1 Subwavelength-Structured Surface Relief Gratings
The sensor incorporates a subwavelength-structured surface (SWS) relief grating with the
grating period being small compared to the wavelength of incident light. This ensures that
no diffractive orders other than the reflected and transmitted zeroth orders are allowed to
propagate. As the grating is illuminated, the incident light propagates into the waveguide
as a leaky mode. The light propagates a very short distance - around 10 to 100 µm - and
then undergoes scattering, coupling with the zeroth order light. This coupling condition
results in a narrow band of reflected wavelengths, which can be modulated by a change in
the dielectric constant of the materials that are in contact with the grating. Material that
is in contact with the surface of the grating increases the optical path length of the coupled
light and therefore changing the maximum wavelength of reflectance.
3.2.2 Hydrostatic Pressure
Using hydrostatic pressure as a perturbant has advantages over other methods, such as
chemical or temperature.[117, 118] The use of hydrostatic pressure mostly affects the
overall volume of the system without changing the internal energy of the analyte and the
solvent system. Applying pressure changes the distances or volumes of the components of
the system at high pressures (>100 kilobar)[118] while keeping the total energy almost
constant.[119] Hydrostatic pressure causes a shift in equilibrium for the system with the
smallest volume, according to Le Chatelier’s principle.[120] At lower pressures (<2
kilobar), volume changes associated with solvation are observed. Ionic interactions are
destabilized due to pressure packing water molecules around charges and results in a
volume reduction on the order of 25 mL/mol.[121, 122] Hydrophobic interactions are also
disrupted under high pressure due to a dense packing of water molecules, with a volume
change on the order of 20 mL/mol.[122] In order to calculate the pressure dependence of
refractive indices we need to combine standard equations of optics and thermodynamics
into a theoretical model. The Lorentz-Lorentz equation relates density to refractive index:
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RLL =
n2 − 1
n2 + 2
1
ρ
=
4pi
3
α′NA (3.1)
where RLLrepresents the Lorentz-Lorentz constant, n represents the refractive index, ρ
represents the fluid density, α′represents the polarizability volume, and NA represents
Avogadros number.[108, 123] The Lorentz-Lorentz equation is an extension of the
Clausius-Mosotti equation in the region of optical frequencies and links Maxwells theory
with the atomistic theory of matter.[123] The isothermal compressibility can be calculated
by using the following equation that relates changes in density and pressure:
βT =
1
ρ◦
∗ ∆ρ
∆P
(3.2)
where βT represents the isothermal compressibility and P represents the applied pressure.
3.3 Methods
3.3.1 Materials
Sucrose, sodium chloride (NaCl), ethanol, and all other chemicals were purchased from
Sigma Aldrich (St. Louis, MO, USA). BIND sensor chips were graciously provided by Dr.
Brian Cunningham. The pressure bomb and the high pressure cuvette were machined in
the Life Sciences Machine Shop. Buffers were prepared with 18 MΩ deionized water and
filtered prior to use.
3.3.2 High Pressure Cuvette and Apparatus
Analyte solutions were inside of a custom designed cuvette manufactured out of
polycarbonate. The cuvette was designed so that it could hold a BIND Assay grating
sensor that would be cut out of 96-well plate backing. The grating is mounted in the
cuvette, on top of a sealing O-ring, and then sealed with a faceplate that is held together
by four screws. The cuvette has a liquid reservoir that allows the fluid to come into contact
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with the sensor. A fluid-filled cap is placed on the stem of the cuvette. The details of the
cuvette are shown in Figure 3.1. As the cuvette is inside the pressure chamber and the
pressure is increased, the cap slides down the stem, increasing the pressure inside of the
cuvette as well. Using this method, there is no difference in the pressure on both sides of
the BIND Assay grating sensor, causing distortions in the sensor geometry. The cuvette
was housed inside a high pressure bomb machined out of steel with quartz windows
designed based on previously published work.[118, 124] Hydrostatic pressure was generated
by a single stage pump (High Pressure Equipment, Erie, PA) using absolute ethanol as the
pressurizing fluid. Refractive index changes were monitored by measuring the shift of the
peak of the reflected resonant wavelengths (PWV). (Figure 3.2)
3.3.3 BIND Assay Sensors
The sensors are fabricated on a material with a low refractive index that is coated with a
thin layer of a higher refractive index material, as previously described.[76] Briefly, the
sensors utilize a one-dimensional surface grating structure. Using deep-UV lithography, the
sensors were fabricated on plastic substrate and then coated with a thin layer of titanium
oxide. The grating period is 550 nm and the depth of the grating is 170 nm. The thickness
of the titanium oxide coating is 120 nm. The sensors are fabricated on sheets that fit the
backs of standard 96-well plates, and single sensors are then cut out from the sheets,
cleaned using a serial ethanol and water rinse, and mounted inside the high-pressure
cuvette, which is detailed above.
3.4 Results and Discussion
3.4.1 BIND Assay Verification
In order to verify that the BIND Assay sensor was accurately measuring the refractive
index as it was mounted inside the cuvette and placed inside the pressure cell, the
refractive index of several concentrations of NaCl was first measured and the measured
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values compared to the calculated values. This was repeated for four different sensors and
in order to account for any discrepancies in mounting and orientation, the relative
difference in refractive index from pure water is what was recorded instead of absolute
refractive index. As can be seen in Figure 3.3, the slope of measured ∆n vs. calculated ∆n
is close to 1 and the measured values correspond to the calculated values.
The same set of measurements was repeated for several concentrations of sucrose and
compared to calculated values. Again, the measurements were repeated for two different
sensors, so the difference in refractive index rather than the absolute refractive index is
used. The slope of measured ∆n vs. calculated ∆n is close to 1 and the measured values
correspond to the calculated values. Additionally, in order to eliminate any possible
interactions between charged ions and the grating coating, solutions of ethanol and water
were examined. In order to minimize interactions between the plastic sensor and the
ethanol inside, only concentrations of 50% ethanol and lower were used. Two unique
sensors were used in four separate trials, which resulted in the averaged data points
presented. Again, the slope of measured ∆n vs. calculated ∆n is close to 1 and the
measured values correspond to the calculated values.
This set of experiments validates the use of the BIND Assay sensors for the purpose of
measuring the change in refractive index. All of these experiments were done in ambient
pressure and temperature and there was no external pressure applied to the sensors.
However it is crucial to demonstrate the utility of the method and instrumentation before
applying pressure. These experiments showed that by modulating the concentration of
salts in the solution, the sensors were able to detect the changes in refractive index. This
was accomplished using solutions with known refractive indices. The sensors were
additionally able to detect changes in refractive index with solutions which contained no
charged species, eliminating any interactions between the grating coating and charged ions.
3.4.2 Compressibility
To calculate the compressibility of the same solutions, the change in PWV was monitored
as pressure was increased from 0 to 21,000 psi. The PWV was recorded in pressure jumps
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of 3,000 psi until the final pressure was reached. The PWV was then converted into
refractive index[125] and plotted on a graph against pressure. (Figure 3.6) The
compressibility of these solutions was calculated using the Lorentz-Lorentz equation
(Equation 3.1) combined with the isothermal compressibility equation (Equation 3.2).
(Table 3.1) Interestingly, while the compressibility initially increases from pure water, as
the concentration of NaCl continues increasing, the compressibility of the solutions first
increase, then reaches a plateau, and eventually starts dropping.
The pressure dependence of the refractive index of various concentrations of sucrose
solutions was also measured in the same fashion. (Figure 3.7) The compressibility of these
solutions is calculated using the Lorentz-Lorentz equation combined with the isothermal
compressibility equation. (Table 3.2) The results show that as with solutions of NaCl, the
refractive index of sucrose solutions increases both with increasing concentration and with
increasing pressure. In contrast to the compressibility of NaCl, the results show that as the
concentration of sucrose increases, the compressibility of the solution also increases and
does not reach plateau or come back down.
Finally, the pressure dependence of the refractive index of aqueous solutions of ethanol
was measured. Higher concentrations of ethanol were not measured since an increase in
concentration of ethanol combined with an increase in pressure caused degradation of the
plastic component of the sensor. This was most likely caused by a partial dissolution of the
plastic substrate on which the sensor is fabricated. (Figure 3.8) The compressibility
calculations show that the compressibility does increase with increasing ethanol
concentration. (Table 3.3) This behavior is expected, as the compressibility of pure ethanol
is almost three times that of pure water.[126] Again, this is in contrast to the NaCl
solutions measured above.
3.5 Conclusions
This chapter demonstrates the implementation of a resonant optical biosensor under
hydrostatic pressure for measuring changes in refractive index and calculating
compressibility of solutions of NaCl, sucrose, and ethanol. An experimental set-up was
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built and tested using solutions of different refractive indices. Initially, the BIND Assay
sensors were were verified to be accurately measuring refractive indices of the three
solutions. After verifying, the pressure dependence and compressibility of the solutions
using the BIND Assay sensors under hydrostatic pressure from 0 to 21,000 psi was
measured. The Lorentz-Lorentz equation combined with the isothermal compressibility
was used to calculate the compressibility of these solutions. Based on these results, we
have shown that the BIND Assay sensors are a practical system to be used under
hydrostatic pressure to detect changes in refractive index. Additionally, this experimental
set up could be used to study other systems of interest under hydrostatic pressure, such as
thin films[108], and molecular recognition events.[109, 110] Future works employing this
system can be combined with the Nanodisc technology in order to explore the molecular
recognition events of membrane proteins, which is further addressed in the last chapter.
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3.6 Figures and Tables
Figure 3.1: A schematic of the custom-machined cuvette used in the high pressure bomb.
The cuvette is machined out of polycarbonate. The sensor is placed on top of the hole
present in the middle of the cuvette, with a faceplate holding it down. The faceplate is
held down by 4 screws. A pressure cap goes on top of the stem, pressurizing the inside of
the cuvette as the the pressure outside builds up.
Figure 3.2: Diagram of the high pressure apparatus. The light source is an Oriel tungsten
halogen lamp. The light passes through an IR filter, then is polarized, and is focused into a
fiber optic cable. The cable focus the light onto the sensor inside the pressure cell through
the window and measures the reflected light.
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Figure 3.3: A comparison between measured ∆n values and calculated ∆n values for NaCl.
Figure 3.4: A comparison between measured ∆n values and calculated ∆n values for
Sucrose.
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Figure 3.5: A comparison between measured ∆n values and calculated ∆n values for
Ethanol.
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Figure 3.6: Calculated refractive index values at different pressures for NaCl.
Table 3.1: Compressibility of NaCl
Concentration of NaCl (% by wt.) Compressibility (x10−10m2/N)
0 4.4
2 5.6
4 4.9
8 4.9
16 4.2
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Figure 3.7: Calculated refractive index values at different pressures for sucrose.
Table 3.2: Compressibility of sucrose
Concentration of Sucrose (% by wt.) Compressibility (x10−10m2/N)
0 4.4
10 5.4
15 6.2
20 6.3
25 7.3
30 7.6
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Figure 3.8: Calculated refractive index values at different pressures for ethanol.
Table 3.3: Compressibility of ethanol
Concentration of Ethanol (% by wt.) Compressibility (x10−10m2/N)
0 4.4
10 6.8
20 7.1
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CHAPTER 4
INTERFACING DNA-LABELED NANODISCS WITH
PHOTONIC MICRORING RESONATORS
4.1 Introduction
Nanodiscs have previously been interfaced with a variety of surface-based biosensors,
including SPR and silicon photonic microring resonators.[25, 66, 68] However, the
published studies utilizing Nanodiscs on biosensors have a need for improved methods.
First, most studies have focused on a single protein-protein or protein-lipid interaction. For
example, SPR studies have examined the interaction between blood coagulation factors
and PS lipid head groups[29, 43]. Commercial SPR instruments are limited in their
multiplex capabilities, utilizing one or two channel sensor chips. This inherently limits the
number of studies performed on a single chip and shows a need for improved multiplexity
of instruments. Multiplexing has been partially addressed by coupling Nanodiscs with the
silicon photonic microring resonators[68] but this method requires depositing Nanodiscs by
hand onto the sensor chips. This hand deposition method is prone to user error and also
limits the number of different Nanodisc types which can be spotted onto the chip, as the
dimensions of the chip are small. The need for a system which has high multiplexity, high
throughput, and limits manual manipulation is required for systems involving multiple
targets. A system incorporating all of these features would decrease analysis time, reagent
consumption, and reduce variability between trials.
Silicon photonic microring resonators are biosensors which rely on the optical coupling of
internally reflected light from a linear waveguide into micrometer sized ring waveguides.
The evanescent wave generated from the internally guided light probes the environment
around the wave guide and monitors for a shift in optical density, or refractive index, which
would result from a biomolecular interaction near the surface of the waveguide. The
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evanescent wave penetrates the surface of the rarer medium, in this case the solution, and
decays exponentially with distance from the surface of the waveguide. A shift in refractive
index is displayed as a shift in the resonance wavelength and the change is continuously
monitored and measured. These biosensors are incredibly scalable, highly multiplexable,
and easily manufactured using well-established semiconductor fabrication methods.[127]
Microring resonator biosensors have been previously used for studying protein-protein
interactions, detecting nucleic acids, and measuring biomolecular binding kinetics
parameters.[128, 129, 130] A study detailing the coupling of Nanodiscs to this biosensor
platform by using physisorption for the immobilization strategy has been previously
published and this work seeks to build upon the previously published methods.[68]
This chapter details the extension of the previously published work by utilizing the
specific sequence recognition of complementary DNA strands. An important advantage of
this approach is that DNA is remarkably robust in contrast to proteins and complementary
antibodies when it comes to long term storage. Sensor chips can be functionalized with
DNA, and then dried and stored long term under conditions which would denature
proteins and antibodies. Another advantage of using DNA as the attachment strategy is
the capacity of DNA to allow extraordinarily high levels of multiplexing - strands which
have n bases can encode up to 4n unique sequences. For example, this study employs labels
which are 21 base pairs in length, allowing for close to 200,000 unique identities of labels.
Nanodiscs were labeled using ssDNA by an initial chemical modification of a cysteine
mutant of MSP with a heterofunctional crosslinker. The crosslinker provides an
N -Hydroxysuccinimide (NHS) group, which covalently binds to an amine terminated
ssDNA chain, as well as a reactive maleimide group, which can react with a thiol group of
a cysteine residue present on the MSP. Using this strategy, eight different MSP variants
were created with eight unique DNA sequences. The complementary ssDNA was
immobilized to the biosensor surface using a molecular printing system, limiting the
manual manipulation of the assay. The functionalization of the microring resonator chips
with eight different Nanodisc systems provided a multiplexed platform for elucidating the
binding parameters of blood coagulation factors and charged lipids. This work not only
builds upon the previously published methods, it also lays the groundwork for multiplexed,
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high-throughput assays utilizing lipid bilayers of varying composition.
4.2 Methods
4.2.1 Materials
The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-L-serine] (POPS), 1,2- dimyristoyl-sn-glycero-3-
phosphocholine (DMPC), and 1,2-dimyristoyl-sn-glycero-3-phospho-L-serine (DMPS) were
purchased from Avanti Polar Lipids (Alabaster, AL, USA). The cysteine mutant,
MSP1D1 D73C was expressed and purified as described previously.[30, 31] Tissue factor
(TF) was generously provided by the research group of Prof. James Morrissey. The
crosslinker m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS),
bis(sulfosuccinimidyl)suberate (BS3), StartingBlock Blocking Buffer, and
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) were purchased from ThermoFisher
Scientific (Waltham, MA, USA). Single stranded DNA (ssDNA), terminated with a
reactive, primary amine group was purchased from Integrated DNA Technologies
(Coralville, IA, USA). Vivaspin Protein Concentrator Spin Columns were purchased from
GE Life Sciences (Pittsburg, PA, USA). (3-Aminopropyl)triethoxysilane (APTES),
Ethylenediaminetetraacetic acid (EDTA), sodium cholate, dimethyl sulfoxide (DMSO),
Amberlite XAD-2 hydrophobic beads, and all other chemicals were purchased from Sigma
Aldrich (St. Louis, MO, USA). Buffers were prepared with 18 MΩ deionized water and
filtered prior to use.
4.2.2 MSP Labeling with ssDNA
When received, MBS is dissolved in anhydrous DMSO at a concentration of 159 mM and
kept as a stock solution, stored in a sealed desiccator at 4 ◦C. Stock MBS is diluted down
to 5 mM prior to use in reaction to prevent precipitation in an aqueous buffer. DNA is
dissolved in PBS buffer 1 (10 mM PBS, 3 mM EDTA, pH 8) to a concentration of 100 µM.
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MBS and DNA are combined at a ratio of 100:1 MBS:DNA and final concentrations of 1
mM MBS and 10 µM DNA. The reaction is incubated on a shaker at room temperature for
30 minutes. During that reaction time, the cysteine residue of MSP1D1 D73C is reduced
through the use of TCEP. This is accomplished by adding TCEP and cholate to a solution
of MSP with final molar ratios of 1:5:25 of cholate:MSP:TCEP. The MSP-cholate reaction
is allowed to proceed on a shaker at room temperature for 15 minutes. After the
MBS-DNA reaction has been incubated for 30 minutes a buffer exchange is performed,
using Vivaspin 5,000 MWCO concentrator spin columns into PBS buffer 2 (10 mM PBS, 3
mM EDTA, pH 6.5). The buffer exchange also accomplishes the removal of excess
crosslinker. After buffer exchange, MSP and DNA are combined such that the molar ratios
are 1:10 of MSP:DNA and the reaction is incubated on a shaker at room temperature for
two hours. It is important to note that a low concentration of MSP will produce low
labeling efficiency, so the concentration of MSP is kept ≥ 75 µM. Labeling was confirmed
and efficiency was estimated via gel electrophoresis. The labeled MSP can be separated
from the unlabeled DNA via size exclusion chromatography (SEC).
4.2.3 Nanodisc Self-Assembly and Purification
Preparation of Nanodiscs with POPS[29] and TF[43] have been previously described in
detail and the same general protocol was followed. Briefly, for Nanodiscs containing a
mixed system of POPC:POPS, lipids were combined in the appropriate ratios from
chloroform stocks, dried under nitrogen, dessicated overnight, and re-suspended in sodium
cholate containing buffer. The solubilized lipids were combined with DNA-labeled
MSP1D1 D73C at the appropriate ratio. At this point, for Nanodiscs requiring the
addition of tissue factor, a Triton X-100 solubilized stock of TF was added to the solution
at the ratio of 10:1 of MSP:TF. For ”empty” Nanodiscs, no additional reagents are
necessary. Detergent removal was accomplished with Amberlite XAD-2 beads. Samples
were purified via a Superdex 200 Increase SEC column (1.6 x 30 cm) at flow rate of 0.75
mL/min and the appropriate peak fractions collected and pooled. The concentration of
Nanodisc solutions was determined by a Bradford assay.
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4.2.4 Purification of TF-Nanodiscs
Nanodiscs with incorporated TF were purified from ”empty” Nanodiscs containing only
lipids. This is accomplished through a genetically encoded HPC4 tag on the TF protein.
After the Nanodiscs were assembled and purified on the Superdex column, CaCl2 was
added to the samples, so that the final concentration was 2 mM. Samples were loaded on
an HPC4 resin column equilibrated in HBS-50 buffer (30 mM HEPES, 50 mM NaCl, 5 mM
CaCl2). The column was washed with 3 mL of HBS-50 to wash away empty Nanodiscs.
The bound discs were then eluted with 2 mL of HBS-50 containing 5 mM EDTA. A buffer
exchange was performed through dialysis to remove calcium and EDTA and put the
Nanodiscs into PBS buffer. The concentration of Nanodiscs was again determined with a
Bradford assay.
4.2.5 Microring Resonator Chips and Instruments
Microring resonator instrumentation and sensor chips were obtained from Genalyte, Inc.
(San Diego, CA) and have been described previously.[128, 130] Arrays of silicon photonic
microrings were fabricated of silicon oxide substrates using well established and
characterized semiconductor fabrication methods. Each 6x6 mm microchip contained 128
microrings, each ring 30 µm in diameter, 500 nm wide and 200 nm tall, with adjacent
linear waveguides. Input and output diffractive grating couplers at the end of the linear
waveguides allow independent measurements to be made at each ring using a tunable
cavity diode laser centered at λ=1560 nm. Light is coupled from the linear waveguide into
the microring only at wavelengths that travel at an integer multiple of wavelengths around
the ring, with the resonance condition given by:
mλ = 2pirneff (4.1)
where, m is an integer, r is the microring radius, and neff is the effective refractive index
sampled by the evanescent wave. Bio-molecular binding events close to the ring surface
cause a change in local refractive index and are measured as a shift in the resonance peak
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wavelength (PWV) in units of ∆pm. The magnitude of the wavelength shift is directly
proportional to the amount of bound analyte. Solution is flowed over the surface through a
custom-built microfluidic chamber that features channels defined by a 0.007 inch thick
Mylar gasket (RMA Laser, El Caljon, CA, USA). Total shifts were quantified at saturation
of the Nanodisc or binding protein sample.
4.2.6 Functionalization of Resonator Chips
Chips were initially immersed in acetone for 2 minutes with continuous shaking at room
temperature. The chips were then immersed in acetone with 5%
(3-Aminopropyl)triethoxysilane (APTES) for 4 minutes with continuous shaking at room
temperature in order to provide a reactive amine on the surface. Afterwards, the chips
were immersed in fresh acetone for 2 minutes to remove excess APTES, fresh isopropanol
for 2 minutes, and dried under nitrogen. The chips were hand-spotted with 20 µL of 5 mM
BS3 in 2 mM acetic acid solution, allowed to incubate for 3 minutes and washed under
water and dried with nitrogen. Note:Functionalization should be completed within 20
minutes of dissolving the BS3 in acetic acid. DNA was spotted onto the ring resonators
using the Nano eNabler Molecular Printing System (Bioforce Nanosciences, Ames, IA)
with a concentration of 100 µM. After spotting DNA, the chips were immersed in
StartingBlock Blocking Buffer and allowed to incubate for 1 hour under continuous shaking
at room temperature. Excess solution was removed and chips were rinsed with 18 MΩ
water and dried and stored in a sealed desiccator at 4 ◦C until ready to be used. Nanodiscs
were immobilized on the microchip substrate by flowing Nanodisc solution through 1-, 2-,
or 4-channel microfluidic gaskets. After immobilization of Nanodiscs, the chips were
blocked by flowing 2% bovine serum albumin (BSA) solution to prevent nonspecific
binding to the silica surface. A flow rate of 10 µL/min was used for all steps.
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4.3 Results and Discussion
4.3.1 DNA-Labeled MSP
Labeling of the MSP with DNA was achieved through the use of a heterofunctional
crosslinker. The crosslinker which was used in this study was chosen based on several
characteristics. First, the crosslinker had to react with both the DNA and the MSP in
order to link them, but not in such a way that it would crosslink the molecules to another
of the same kind. This required two reactive groups on the crosslinker. One of the groups,
the maleimide, would react with the cysteine residue of the MSP mutant, while the other
group, the N-Hydroxysuccinimide (NHS), would react with the primary amine-modified
ssDNA. The labeling was achieved by following the protocol outlined in the methods
section. The labeling reaction was further optimized by adjusting concentrations of all the
reagents. After optimization, an estimated labeling efficiency of >80% was achieved.
(Figure 4.1) After labeling was complete, a separation of labeled MSP from unlabeled MSP
was possible via SEC.(Figure 4.2) Prior to self assembling discs, the labeled MSP was
separated and collected.
4.3.2 Nanodisc Loading on Chips
After self-assembly and purification, the Nanodiscs were immobilized on a functionalized
microring resonator chip. The chip was functionalized according to the methods outlined
above. In order to minimize the materials used, only two DNA strands were used on the
chip, A and B, as a proof of concept. The Nanodiscs which were in the flow channel were
only labeled with DNA strand B. As the Nanodiscs started flowing across the chip, only
the sensors with the complementary DNA strand had a shift in PWV. The rest of the rings
did not observe a shift in PWV therefore no binding was observed on those rings. (Figure
4.3) This shows that only the rings with the complementary DNA showed binding of
Nanodiscs. The other rings, which either had non-complementary DNA or no DNA
attached, did not show any binding of Nanodiscs. Therefore, this validates the method and
shows that it is possible to use this method in order to address individual rings with
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individual species of Nanodiscs labeled with ssDNA.
4.3.3 Annexin Binding to Anionic Lipids
In order to determine whether Nanodiscs immobilized on the surface of the rings were
viable for monitoring specific interactions, binding of annexin was monitored for the
channels containing POPC and POPC:POPS Nanodiscs. Annexins interact with
membranes in a calcium dependent manner which allows for the interaction between
proteins and anionic lipids such as POPS.[131] Binding of annexin was only observed on
microrings functionalized with Nanodiscs that contained anionic POPS lipids (Figure 4.4).
Switching to calcium-free buffer immediately caused dissociation of the bound annexin
from the POPC:POPS Nanodiscs, demonstrating the calcium-dependence of this
interaction. The data shown here establishes the utility of DNA-labeled Nanodiscs on the
microring resonator array as an effective strategy for addressable immobilization of lipid
bilayers for biomolecular interaction assays.
4.4 Conclusions
In this chapter, it was demonstrated that Nanodiscs can be labeled using ssDNA and then
interfaced to photonic microring resonator chips utilizing the specific recognition of ssDNA
strands. By combining the two novel technologies of Nanodiscs and microring resonators, a
high throughput, high-multiplexity phospholipid array was created that could be used to
elucidate the details of a variety of biological membrane events. This strategy offers the
ability to individually address microring resonators with specific species of Nanodiscs,
without using hand spotting techniques. Nanodiscs were successfully chemically labeled
with individual DNA strands by utilizing the single cysteine mutant scaffold protein and a
crosslinking strategy. The microring resonator chips were then labeled with complementary
DNA strands and the binding of labeled Nanodiscs to the complementary DNA
immobilized on the resonators was observed. The binding was specific and very little
nonspecific binding of non-complementary DNA was observed. The utility of the developed
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assay was demonstrated by monitoring the binding of annexin to POPS:POPC Nanodiscs.
Binding of annexin to POPS-containing Nanoidscs was seen, while no binding was seen of
annexin to POPC-only Nanodiscs.
This work presents an extension of the work initially demonstrating the coupling of
Nanodiscs and photonic microring resonators.[68] This implementation of the assay
provides higher multiplexity and provides the potential for having an unrivaled complexity
of lipid bilayers on a single chip. Current generation microring resonator chips contain 128
individually addressable rings, providing the opportunity for a single chip assay containing
as many as 128 different Nanodisc populations. This number is easily achievable using the
DNA-labeling approach and the only bottleneck is the size of the chip itself. Furthermore,
this assay presents an opportunity to create arrays that can continuously monitor the
binding kinetics of multiple species of target proteins or pharmaceuticals. This supports a
shift toward personalized, bedside medical devices, able to continuously monitor vital
statistics.
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4.5 Figures and Tables
Figure 4.1: SDS-Page gel showing the that the MSP has been labeled with the ssDNA.
Lane one is the protein ladder. Lane 2 is unlabeled MSP. Lanes 3 through 10 are the
products of the labeling reaction. The thicker bands shows the DNA-labeled MSP and the
thinner bands show the unlabeled MSP. The labeling efficiency is >80%.
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Figure 4.2: SEC chromatogram showing the separation of DNA-labeled vs. unlabeled
MSP. The inset shows that the majority of the first peak is DNA-labeled MSP, whereas the
majority of the second peak is unlabeled MSP.
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Figure 4.3: Output of the ring resonator instrument showing Nanodiscs labeled with DNA
B strands bound to rings with the complementary DNA and did not bind to the rings
labeled with a different DNA strand. The blue traces represent the rings with strand B
attached to them. The orange traces represent the rings with strand A attached to them.
The gray traces represent control rings with no DNA attached to them.
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Figure 4.4: Output of the ring resonator instrument showing annexin binding to discs with
POPS:POPC and no binding to discs with only POPC. The blue traces represent rings
with POPS:POPC Nanodiscs attached to them. Switching to calcium-free buffer
immediately caused dissociation of the bound annexin from the POPC:POPS Nanodiscs,
as can be seen around 22 minutes.
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Table 4.1: Sequences and melting temperatures of the eight ssDNA labels used in this
work. The sequences were designed so that the melting temperatures would be similar,
ensuring that the hybridization strengths of the molecules are similar.
Label Sequence Tm (
◦C)
A 5’-NH3-AAT CCT GGA GCT AAG TCC GTA-3’ 55.0
B 5’-NH3-AGC CTC ATT GAA TCA TGC CTA-3’ 54.0
F 5’-NH3-AAT CAG GTA AGG TTC ACG GTA-3’ 53.3
G 5’-NH3-TGC TCG GGA AGG CTA CTC CTA-3’ 58.6
H 5’-NH3-ACG CAC CGC AGT TTG GTC AAT-3’ 60.1
K 5’-NH3-ATA ATC TAA TTC TGG TCG CGG-3’ 52.3
L 5’-NH3-AGT GAT TAA GTC TGC TTC GGC-3’ 55.0
M 5’-NH3-AAC AGG TTC AGA ATC CTC GAC-3’ 56.9
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CHAPTER 5
DEVELOPMENT OF MICROFLUIDIC PLATFORM
FOR THE ASSEMBLY OF NANODISCS
5.1 Introduction
Membrane proteins are usually expressed at low levels throughout the natural proteome of
organisms and their recombinant over-expression in host cells is often difficult and costly.[6]
This creates a limitation on available material for biomolecular studies involving membrane
proteins. The process is further complicated by a greater initial requirement for material in
order to optimize incorporation of the target proteins into Nanodiscs - a process inherent
to all systems of solubilization. Even though recent molecular biology advancements have
simplified construction of DNA sequences for expression, the Nanodisc incorporation
optimization, and therefore protein production, remain a bottleneck in the process.[132] In
order to decrease sample volume requirements, there is a need for a platform which can
rapidly and efficiently prepare and purify small volumes of Nanodisc-incorporated
membrane proteins. Small scale studies are needed for cost- and time-effective screening of
assay conditions prior to scaling up reactions.[133, 134, 135]
The Nanodisc platform has become an integral and powerful method that has been
optimized for the solubilization of membrane proteins. However, the incorporation of each
target membrane protein has to be individually optimized. This is often a time and sample
consuming procedure but is necessary in order to achieve maximum Nanodisc
incorporation as well to maximize the retention of activity in the target protein. The
optimization usually involves the screening of several detergents, screening multiple species
of lipids, as well as adjusting the ratios of lipids and target protein. Multiple membrane
proteins have been successfully incorporated into Nanodiscs,[28, 62, 136] though several
other target proteins have proven to be difficult and efforts into incorporation have been
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fruitless up to this point. The division in success of incorporation of target proteins has
been primarily due to the low availability of starting materials and a need for optimization,
therefore a dire need exists for a system which uses small volumes of sample and is able to
reliably optimize the incorporation of target proteins into Nanodiscs.
Microfluidic systems have emerged as a robust and reliable platform for the
miniaturization of existing tools in molecular biology in order to increase speed and
throughput as well as decrease sample cost.[137, 138] In addition to the small size, the
ability to add multiple functions and multiple assays on a single device and modularity of
microfluidic systems has advanced automation in protein processing and characterization
studies.[139] The size and production simplicity of microfluidic technology inherently make
the approach amenable to creating modular, multi-step purification systems on a single
device. Microfluidic systems have been applied to a variety of problems, including protein
purification, protein extraction, point-of-care diagnostics, and chemical and biological
analysis.[140, 141, 142, 143] Such devices have incorporated multiple channels, separation
columns, micro-reactors, and even cell lysis chambers.[144]
This work details the development of a microfluidic platform for the assembly of
Nanodiscs. The device is fabricated out of polydimethylsiloxane (PDMS) and glass slides,
with a mixing channel and a channel for the removal of detergent. The design of the device
is modular, such that multiple purification steps can be incorporated on a single device,
including metal affinity and size purification. The device can be used to generate
Nanodiscs, both empty - having no target membrane protein - and with an incorporated
protein. Because of the intrinsic property of handling small volumes of materials, this
device is extremely applicable in the optimization of target protein incorporation. It is
shown that Nanodiscs come out of the device in a matter of minutes, with and without
incorporated protein. Additionally, a continuous gradient can be programmed such that
optimization of ratios can be achieved on the fly, without preparing multiple samples,
requiring multiple steps of purification and analysis.
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5.2 Methods
5.2.1 Materials
The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-L-serine] (POPS), 1,2- dimyristoyl-sn-glycero-3-
phosphocholine (DMPC), and 1,2-dimyristoyl-sn-glycero-3-phospho-L-serine (DMPS) were
purchased from Avanti Polar Lipids (Alabaster, AL, USA). The scaffold protein, MSP1D1
was expressed and purified as described previously.[30, 31] CYP3A4 was expressed with a
histidine affinity tag from the NF-14 construct in the pCWOri+ vector, purified, and
incorporated into POPC Nanodisc lipid bilayers as previously described.[41, 83, 102, 103]
Pierce Detergent Removal Resin was purchased from ThermoFisher Scientific (Waltham,
MA, USA). Ethylenediaminetetraacetic acid (EDTA), sodium cholate, dimethyl sulfoxide
(DMSO), Amberlite XAD-2 hydrophobic beads, and all other chemicals were purchased
from Sigma Aldrich (St. Louis, MO, USA). Buffers were prepared with 18 MΩ deionized
water and filtered prior to use.
5.2.2 Microfluidic Design and Fabrication
Microfluidic devices were designed to incorporate a mixing channel as well as detergent
removal channel. The mixing channel is in a serpentine shape capable of mixing the three
separate components that are introduced in the three inlets. The detergent removal
channel incorporates posts to enhance structural stability. The device master was designed
in AutoCAD (Autodesk Inc., San Rafael, CA) and a mask was printed by . The masters
were made by spin coating SU8-2100 on a wafer to produce a thickness of . The mask
design was transferred using standard photolithography techniques. Feature height was
validated using optical profilometry. PDMS was poured on top of the master, air bubbles
removed via vacuum, and subsequently cured at 80 ◦C for two hours. The PDMS was
removed from the master, cut out to individual devices, and holes punched for inlet and
outlet ports. Glass slides were cleaned in a plasma cleaner and the PDMS adhered to the
cleaned glass slides. Standard silicone tubing was used for the connection between syringes
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and device inlets as well as the outlet of the devices.
5.2.3 Microfluidic Assembly of Nanodiscs
Non-Mixing In order to assemble empty Nanodiscs, a solution of detergent-solubilized
lipids and purified MSP1D1 was flowed across a device, filled with detergent removal resin.
Flow rates were constant, set at 30 µL/min, and controlled by infusion syringe pumps
(Harvard Apparatus, Holliston, MA). In order to assemble CYP3A4 into Nanodiscs on the
device, a solution of detergent-solubilized lipids, purified MSP1D1, and purified,
detergent-solubilized CYP3A4 was flowed across the device. All solutions and device were
under temperature-controlled conditions, depending on the identity of the lipid used so
that the temperature was slightly above the transition temperature. The eluent was
collected in 50 µL fractions and characterized by SEC and AFM.
Mixing In order to assemble empty Nanodiscs, three solutions were flowed into separate
channels: detergent-solubilized lipids, purified MSP1D1, and buffer. The three separate
channels combine into a serpentine, mixing channel which mixes the three constituents
before flowing into the detergent removal channel. The three solutions are placed into
separate syringes and each syringe is controlled by an infusion syringe pump to have a
constant flow rate of 10 µL/min. Incorporating CYP3A4 into Nanodiscs with a mixing
channel calls for a similar protocol, changing the buffer solution to a solution of
detergent-solubilized CYP3A4 in the third channel. All solutions and device were under
temperature-controlled conditions, depending on the identity of the lipid used so that the
temperature was slightly above the transition temperature.The eluent was collected in 50
µL fractions and characterized by SEC.
Lipid Gradient Mixing To assemble empty Nanodiscs, three solutions were flowed into
separate channels: detergent-solubilized lipids, purified MSP1D1, and buffer. The three
separate channels combine into a serpentine, mixing channel which mixes the three
constituents before flowing into the detergent removal channel. The three solutions are
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placed into separate syringes and each syringe is controlled by an infusion syringe pump.
Syringes not containing lipids were flowed at a constant rate of 10 µL/min while the
syringe containing lipids was flown utilizing a programmed gradient beginning at 6.92
µL/min and ending at 13.08 µL/min over the span of 8 minutes and 20 seconds. The same
conditions were repeated for the assembly of CYP3A4-Nanodiscs, replacing the buffer
channel with detergent-solubilized CYP3A4. All solutions and device were under
temperature-controlled conditions, depending on the identity of the lipid used so that the
temperature was slightly above the transition temperature.The eluent was collected in 50
µL fractions and characterized by SEC.
5.2.4 Colorimetric Quantitation of Detergent Removal
The amount of cholate and CHAPS present in solution can be determined colorimetrically,
as described in a published method.[145] Briefly, to quantify the amount of detergent being
removed by the detergent removal resin packed in the microfluidic device, buffer containing
100 mM sodium cholate was flowed through resin bed and 10 µL fractions were collected in
individual polypropylene tubes, diluted to 50 µL and 800 µL of concentrated sulfuric acid
was added. A standard curve was made by preparing 50 µL samples of buffer with
concentrations of sodium cholate ranging from 1 mM to 100 mM before 800 µL of
concentrated sulfuric acid was added. Using the standard curve, the concentration of
sodium cholate of the collected fractions was determined by using a plate reader and
measuring absorbance at 390 nm of 200 µL of each sample on a 96-well plate.
5.2.5 Nanodisc Characterization by SEC
After elution from the microfluidic devices, Nanodiscs were characterized by SEC.
Fractions collected from the microfluidic device were injected onto a Superdex 200 Increase
column (1.6 x 30 cm) (GE Healthcare, Pittsburgh, PA) at a flow rate of 0.75 mL/min and
absorbance monitoring at 280 nm. The resulting chromatograms were compared to a
chromatogram of a standard mixture of proteins - Bovine Serum Albumin (BSA), Bovine
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Liver Catalase, Ferritin, and Thyroglobulin - with hydrodynamic radii in the range of
interest.
5.2.6 Nanodisc Characterization by AFM
AFM images were obtained with a Cypher ES Environmental AFM (Asylum Research,
Santa Barbara, CA) equipped with a fluid cell. To form the surface of Nanodiscs, mica was
glued to 10 mm steel disks and cleaved with cellophane tape. Samples of 10 µL Nanodiscs
were applied followed by 10-20 µL of imaging buffer (10 mM Tris-HCl pH 7.4, 0.15 M
NaCl, 10 mM MgCl2). The use of a PAP pen (Ted Pella Inc., Redding, CA) to
circumscribe an area of mica with a hydrophobic border has been found useful to prevent
flow of solution off the mica. After 10 min, several milliliters of imaging buffer were passed
through the cell to remove any unadsorbed material and the sample was mounted on the
imaging stage. Contact imaging was done under imaging buffer using the thin-legged 310
µm cantilever having a nominal spring constant of 0.01 N/m.
5.3 Results and Discussion
5.3.1 Design and Fabrication of Microfluidic Devices
Devices were fabricated using standard photolithography and PDMS methods. Regular
devices include three inlet ports, a mixing channel in a serpentine shape, consisting of tight
turns and wedge shaped inlets. After the mixing channel, a detergent removal channel is
included, with a height and width of 1 cm each and a depth of 200 µm totalling a volume
of 20 µL. (Figure 5.1). The detergent removal channel has posts spaced throughout the
channel for vertical support. The channel is filled with detergent removal resin using the
resin port. The port is integrated in the device in order to prevent clogging of other
channels. Additionally, the channel contains resin capture posts on both the inlet and the
outlet. (Figure 5.3) The capture regions serve two purposes - to first capture and contain
all of the resin in the channel and second to distribute the initial flow through the entirety
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of the channel. The large device (Figure 5.2) is identical to the regular device, with the
only exception being that the detergent removal channel is larger. Specifically, the channel
is the same width (1 cm) but longer (3 cm), with the depth of the channel remaining the
same, with a total bed volume of 60 µL, allowing for the processing of a larger volume.
To prepare the devices for self assembly, they are initially washed with 18 MΩ deionized
water. The detergent removal channel is filled with Pierce Detergent Removal resin under
positive pressure and the silicone tubing is clamped. The entire device is rinsed with a
series of water, methanol and water for 20 minutes at each rinse. The rinsing is
accomplished using a syringe pump flowing at a constant 20 µL/min. After the final rinse
of water, the device is equilibrated with buffer for 20 minutes at a constant rate of 20
µL/min. At this point devices are ready for the assembly of Nanodiscs.
5.3.2 Colorimetric Determination of Detergent Removal
To quantitate the detergent removal capability of the device and the resin, a colorimetric
method was employed, based on a previously published method.[145] The reaction is
between concentrated sulfuric acid and the hydroxyl group of the cholate ring. (Figure 5.5)
The reaction results in an intense absorption peak centered at 389 nm. A solution of 100
mM sodium cholate was flowed through the device and samples of 10 µL were collected
from the outlet port into Eppendorf vials. The samples were diluted up to 50 µL and 800
µL of concentrated sulfuric acid was added to each tube. To measure the absorbance, three
100 µL fractions were put into individual wells on a 96-well plate. The absorbance was
measured and averaged over the three wells. The absorbance generated at 389 nm was
stable, increasing by only 5% over 4 h.
Using this method, it was determined that a small device could reliably completely
remove cholate from approximately 250 µL of reconstitution mixture. (Figure 5.6) The
process was repeated for the similar bile salt detergent
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), a detergent that is
commonly used in membrane protein studies for its non-denaturing properties.[146] A
solution of 10% CHAPS was flowed over the device and 5 µL fractions were collected and
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diluted up to 50 µL before adding 800 µL concentrated sulfuric acid. The results from the
assay are similar to those of cholate, with the device capable of completely removing
CHAPS from approximately 200 µL of reconstitution mixture. These results show that the
devices are capable of completely removing two common detergents used in protein
purification in a short amount of time. This validates the devices for the use of removing
detergent and assembling Nanodiscs on a short time scale.
5.3.3 Nanodisc Characterization by SEC
Nanodiscs were characterized using SEC by first calibrating the column using a mixture of
four proteins - Bovine Serum Albumin (BSA), Bovine Liver Catalase, Ferritin, and
Thyroglobulin - with hydrodynamic radii in the range of interest. The concentrations of
the proteins were normalized so that they would produce peaks of approximately equal
intensity on the chromatogram. The absorbance at 280 nm was monitored over time.
Well-formed, tightly-packed Nanodiscs display a single, narrow peak between the third and
fourth peak of the standards. Nanodiscs with too few lipids display a shoulder or peak to
the right of the characteristic Nanodisc peak, indicating smaller species, or free MSP. If the
ratio of lipids to MSP is too high, shoulders and peaks to the left of the characteristic peak
are observed, indicating aggregates that are too large to be Nanodiscs. (Figure 5.7)
Nanodiscs coming off the microfluidic device were characterized by SEC, displaying a
characteristic peak, just as expected. At the optimal lipid:MSP ratio, the peak is narrow
and at the expected retention time, indicating well-formed Nanodiscs.
5.3.4 Nanodisc Characterization by AFM
Nanodiscs were further characterized using AFM to show the formation of discs
immediately after eluting off the microfluidic device. Qualitatively, it can be seen that
Nanodiscs have formed on the microfluidic device. The AFM images show that a small
amount of aggregates have formed as well, but the population is primarily well formed
Nanodiscs. This observation supports the idea that the microfluidic is capable of
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assembling Nanodiscs in a matter of minutes, using small volumes of reagents, an inherent
advantage of microfluidic systems. (Figure 5.8)
5.3.5 CYP3A4-Nanodiscs on a Microfluidic Device
To demonstrate the utility of the microfluidic devices in assembling Nanodiscs with an
incorporated membrane protein, CYP3A4 was incorporated into DMPC Nanodiscs on the
microfluidic devices. This was accomplished using all three of the ports on the device and
having the concentration ratio be 1:20:90 CYP3A4:MSP:DMPC. The initial
characterization was performed by SEC, scanning at 280 nm for the general protein
absorbance and at 417 nm for the heme group of CYP3A4. The chromatogram trace
revealed that CYP3A4 seemed to be incorporated into the Nanodiscs, coming out at the
beginning of the characteristic peak and the ”empty” Nanodiscs coming a few seconds
later. (Figure 5.9) This is expected as Nanodiscs containing CYP3A4 have a slightly larger
hydrodynamic radius than those without incorporated protein.
5.3.6 Lipid Gradient Optimization
To further reduce the time and materials requirements of target incorporation, a lipid
gradient was developed. While holding the concentrations of all materials constant, the
flow rate of MSP and buffer/target are held constant and the flow rate of the lipid channel
is varied, according to a programmed gradient. This, in turn, produces a continuous
gradient of lipid:MSP:target ratios that can be used to determine the optimal ratio for
target incorporation. To characterize the Nanodiscs produced by the gradient, 25 µL
fractions were collected and characterized by SEC. To show that the gradient can be
applied in either direction, a gradient started at a low ratio of lipids to MSP and increased,
while a different device started a gradient at a high lipid to MSP ratio and decreased with
time. This was also in order to account for the resin detergent removal capacity. Both
gradients showed that the optimal ratio for DMPC Nanodiscs is somewhere around 90 lipid
molecules to 1 MSP molecule. (Figures 5.10 and 5.11)
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5.4 Conclusions
A modular microfluidic device has been designed and shown to assemble Nanodiscs, both
with and without target proteins incorporated into them, by handling small volumes of
reagents, having available on-chip mixing of reagents, as well as a purification channel. At
this point in time, the purification channel is a wide channel filled with detergent removal
resin, facilitating the self-assembly process of Nanodiscs. The device has further been
shown to produce Nanodiscs by employing a lipid gradient, both starting at a low lipid to
MSP ratio and going up as well as starting at a high lipid to MSP ratio and going down.
The incorporation of a gradient aspect to the microfluidic platform further reduces sample
volume and time cost and increases the utility of these devices in optimizing protocols for
the incorporation of target proteins. Using the microfluidic system developed in this work,
the conditions for inserting a target protein can be optimized by simultaneously screening
several detergents, while varying the lipid ratio using a gradient and collecting small
volumes for analysis. This can be accomplished in a short amount of time, using small
volumes of sample, and reducing the need for production of precious target proteins. The
devices are furthermore modular and can be implemented in series or in conjunction with
other analytical devices.
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5.5 Figures and Tables
Figure 5.1: Schematic of the microfluidic device used in this study. The device has three
inlet ports, a mixing channel, a detergent removal channel, and a Nanodisc outlet port.
Figure 5.2: Schematic of the large device used in this study. The large device is similar to
the smaller devices, with the only difference being the larger detergent removal channel.
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Figure 5.3: Zoomed-in schematic of the bead capture region. The bottom picture is an
actual picture of the device colored with dye. This shows the distribution of the solution
over the entire bed of resin, with the support posts clearly visible.
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Figure 5.4: Zoomed-in pictures of the resin beads within the device after treatments with
water, methanol, and after flowing detergent through the resin bed.
Figure 5.5: The reaction which occurs between sodium cholate and concentrated sulfuric
acid that is behind the colorimetric quantitation assay.
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Figure 5.6: The small device is able to remove detergent from 250 µL of solution before we
see a change in absorbance. The solution which was put through the device in these
experiments was 100 mM cholate while the solution used in Nanodisc assembly is 20 mM
cholate.
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Figure 5.7: Representative chromatogram traces of three preparations of Nanodiscs -
underlipidated (60:1), tight-packed (90:1), and overlipidated (120:1). As can be seen, a
lower than optimal ratio produces peaks to the right of the characteristic peak, indicating
free MSP. An optimal ratio produces a single, narrow, characteristic peak. A higher than
optimal ratio produces peaks to the left of the characteristic peak, indicating the presence
of aggregate species.
73
Figure 5.8: An AFM scan of DMPC Nanodiscs produced by the microfluidic device. The
Nanodiscs are not purified in any way, which is why we see some aggregates. The scan size
is 1 x 1 µm for image A and 500 x 500 nm for image B.
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Figure 5.9: Size exclusion chromatogram showing the purification of Nanodiscs with
CYP3A4 incorporated in them immediately after going through the microfluidic device.
The chromatogram shows monitoring at 417 nm and at 280 nm. The trace at 417 shows
that Nanodisc-incorporated CYP3A4 comes out at the beginning of the characteristic
Nanodisc peak, indicating that CYP3A4 is embedded in the Nanodiscs and ”filled”
Nanodiscs show a slightly larger hydrodynamic radius than ”empty” Nanodiscs.
Figure 5.10: Two graphs showing how the lipid gradient works. The first chart shows the
concentration of lipid as it changes and how the ratio of lipid to MSP changes over time.
The second chart shows the flow rate of all three pumps over time.
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Figure 5.11: Chromatogram traces showing the analysis of DMPC Nanodiscs formed using
the programmed gradient. On the left, the gradient starts at a low lipid ratio and
increases. On the right, the gradient starts at a high lipid ratio and decreases.
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CHAPTER 6
DEVELOPMENT OF A NANODISC DELIVERY
PLATFORM FOR MRI-OPTICAL IMAGING
6.1 Introduction
Noninvasive imaging of cells in vivo is crucial for different clinical applications, including
cancer detection[147], cell tracking[148], and detecting disease markers[149]. Methods for
noninvasive imaging include ultrasound, computed tomography (CT), positron emission
tomography (PET), and magnetic resonance imaging (MRI). Of these methods, MRI is the
best suited for studies over long periods of time as it does not use ionizing radiation or
radioactive tracers and provides high resolution images.[150, 151] MRI contrast agents are
often employed for an enhanced signal, with Gd(III) complexes being the most common in
clinical settings.[152] These agents provide a positive image contrast by decreasing the
proton spin-lattice relaxation time (T1) of water protons.[153] However, these Gd(III)
complexes usually provide low sensitivity which necessitates the use of higher
concentrations. Higher concentrations can lead to complications when used in vivo due to
toxicity, with cases of anaphylactoid reactions reported.[154]
A series of lipohilic Gd(III) contrast agents were synthesized by Thomas Meade and
coworkers[155] for the enhanced labeling of cells. The compounds are composed of one or
three Gd(III) chelates, attached to a set of lipophilic alkyl chains, similar to those present
in the tails of lipid molecules. These contrast agents displayed a significant improvement in
MRI contrast as well as a significant increase in retention by two different cell lines over
the commercially available compounds. Furthermore, the compounds displayed relatively
Reproduced in part with permission from Carney, C.E.; Lenov, I.L.; Baker, C.J.; MacRenaris, K.W.;
Eckermann, A.L.; Sligar, S.G.; and Meade T.J. Nanodiscs as a Modular Platform for Multimodal MR-Optical
Imaging Bioconjugate Chemistry 2015 26 (5), 899-905 Copyright 2015 American Chemical Society. The
published version may be found online at http://pubs.acs.org/doi/abs/10.1021/acs.bioconjchem.5b00107.
This chapter includes significant contributions, including data and figures, from Christiane Carney.
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low toxicities in vitro. However, while the increase in contrast was appreciable, the delivery
system consisted of solubilizing the agents in a detergent and incubating cells with the
solution, which means that it wasn’t easily amenable to the attachment of any peripheral
fluorophores or targeting groups. Furthermore, a higher degree of control over size and
stability of the delivery agent is required for the implementation in vivo.
Incorporation of Gd(III) into nanoparaticles has been utilized as a means to improve the
sensitivity and imaging contrast. Nanoparticles offer several advantageous characteristics
including high loading capacity per particle, modular syntehsis for the application of
multimodal and targeting moieties, and enhancements in efficacy of the contrast
agents.[156] Several metal-based nanoparticles have been used as MR contrast agents;
however, these metallic nanoparticles have been implicated in toxicity due to the
generation of reactive oxygen species generation and releasing of toxic ions.[157, 151] In
contrast, antigenically neutral nanoparticles have been explored as MRI contrast agents,
including liposomoes and high-density lipoprotein (HDL) particles.[70, 71] These
nanoparticles offer similar advantages as their metal-based counterparts, without the
additional toxic side effects. These nanoparticles have been successfully used for cell
labeling and tumor imaging in vivo. [158, 159] Additionally, polymeric delivery agents have
been explored as biocompatible alternatives, offering a more modular design.[160, 161]
Even though these particles are capable of serving as therapeutic delivery agents, they still
lack the stoichiometric control as well as the uniformity present in Nanodiscs.
This chapter details the development of a Nanodisc delivery agent for MRI contrast
agents using Gd(III) complex molecules. Nanodiscs display a greater stability, higher
monodispersity, and much greater stoichiometric control compared to liposomes or
detergent-based systems. They have been used in applications varying from the
solublization of membrane proteins for structural studies[36, 40, 162] to the delivery of
therapeutic phospholipids for the inhibition of respiratory syncytial virus (RSV) in
vivo.[45] Nanodiscs have additionally been coupled to analytical systems, accounting for a
very thorough biophysical characterization.[33, 162] The modularity of Nanodiscs allows for
not only the loading of a variety of lipids and lipophilic molecules but also the attachment
of fluorophores and targeting groups to the MSP. The incorporation of the Gd(III) chelate
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contrast agents into TMR-labeled Nanodiscs was optimized to generate water-soluble
nanoparticles that label cells with high efficiency and produce a significant contrast
enhancement. The labeling of cells with the contrast agents was examined and quantitated
at high and low fields, while the stability and proliferation of the cells was also monitored.
6.2 Methods
6.2.1 Materials
The lipids 1,2- dimyristoyl-sn-glycero-3- phosphocholine (DMPC) were purchased from
Avanti Polar Lipids (Alabaster, AL, USA). The cysteine mutant, MSP1D1 D73C was
expressed and purified as described previously.[30, 31] Tetramethylrhodamine-5-(and -6)
C2 maleimide (TMR) was purchased from Anaspec, Inc (Fremont, CA, USA). Multimeric
and monomeric Gd(III) chelating contrast agents were synthesized and graciously provided
by Christiane Carney. (Figure 6.1) Tris(2-carboxyethyl)phosphine hydrochloride (TCEP)
and Pierce 660 nm Protein Assay Reagent were purchased from ThermoFisher Scientific
(Waltham, MA, USA). Ethylenediaminetetraacetic acid (EDTA), sodium cholate, dimethyl
sulfoxide (DMSO), chloroform, Amberlite XAD-2 hydrophobic beads, and all other
chemicals were purchased from Sigma Aldrich (St. Louis, MO, USA). Buffers were
prepared with 18 MΩ deionized water and filtered prior to use.
6.2.2 Labeling MSP with TMR
MSP labeling was carried out in tris buffered saline (TBS) buffer (50 mM Tris/HCl pH 7.4,
0.3 M NaCl). MSP1D1 D73C was reconstituted to a concentration of 100 µM in TBS.
Sodium cholate was added with a final concentration of 10 µM. TMR was dissolved in
anhydrous DMSO. MSP1D1 D73C was reduced with 4 molar equivalents of TCEP and
incubated at room temperature for 15 minutes. TMR dissolved in DMSO was added to the
reduced MSP1D1 D73C so that the final molar ratio would be 10:1 of TMR:MSP. The
mixture was incubated at room temperature for 4 hours and then overnight at 4 ◦C. The
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following day, one volume equivalent of XAD-2 hydrophobic beads was added to the
solution and shaken at room temperature for 4 hours. Excess dye was completely removed
on a G-25 column. Concentration of MSP1 D73C labeled with TMR can be measured
spectrophotometrically by using 280 nm total protein absorption and using a 0.3 correction
factor to account for the absorption of the TMR dye.
6.2.3 Incorporation of Gd(III) chelate into Nanodiscs
Gd(III) chelate was dissolved in chloroform at a concentration of 10 mM. The general
self-assembly procedure of Nanodiscs with incorporated Gd(III) chelates is as described
previously.[30] Briefly, desired ratios of lipids and Gd(III) chelate were measured out into a
glass tube, mixed together, and dried under N2. The mixture of lipids and contrast agents
was further dried in a vacuum desiccator overnight. The mixture was reconstituted with
0.1 M sodium cholate so that the final concentration of sodium cholate would be twice that
of the total lipid/chelate concentration. Labeled MSP1D1 D73C was added to the mixture
in a ratio of 90:1 lipid:protein. The mixture was incubated at 25 ◦C for 20 minutes before
adding XAD-2 hydrophobic beads for the removal of detergent. The reconstitution mixture
was incubated at 25 ◦C overnight. The hydrophobic beads were removed using a disposable
column and samples were purified via a Superdex 200 Increase column (1.6 x 30 cm). Total
Nanodisc concentration was measured using a Pierce 660 nm Protein Assay.
6.2.4 Cell Labeling
Either 25,000 HeLa cells or 30,000 MCF7 cells were seeded in a 24-well plate for labeling
experiments. Cells were incubated with multimeric or monomeric Nanodiscs in media at
concentrations of 01 µM (Nanodisc concentration) for 24 h (180 µL dose). Cells were
washed with 2 x 500 µL PBS, detached with trypsin, and centrifuged at 1000g for 5 min at
4 ◦C. The media was aspirated and the cells were re-suspended in 200 µL media. An
aliquot of 50 µL was used for cell counting and 130 µL was used for analysis of Gd(III)
content by ICP-MS.
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6.2.5 Relaxivity Measurements
For 1.41 T relaxivity measurements, solutions of ND1 and ND2 were prepared in 20 mM
Tris buffer (pH 7.4). T1 and T2 were determined on a Bruker mq60 minispec NMR
spectrometer at 1.41 T (60 MHz) and 37 ◦C using an inversion recovery pulse sequence
with 4 averages, 15 s repetition time, and 10 data points (Bruker Canada; Milton, Ontario,
Canada). For 7 T relaxivity measurements, MR imaging and T1 measurements were
performed using a Bruker Pharmscan 7 T imaging spectrometer according to previously
described methods.[155] Briefly, a rapid-acquisition rapid-echo (RARE-VTR) T1-map
pulse sequence, with static TE (11 ms), variable TR (150, 250, 500, 750, 1000, 2000, 4000,
6000, 8000, and 10000 ms) values, field of view (FOV) = 25 x 25 mm2, matrix size (MTX)
= 256 x 256, number of axial slices = 4, slice thickness (SI) = 1.0 mm, and averages
(NEX) = 3 was used. Relaxivity at 7 T was determined using serially diluted solutions of
multimeric and monomeric Nanodiscs.
6.3 Results and Discussion
6.3.1 Labeling MSP with TMR and Optimization of Loading
The labeling of MSP with TMR was accomplished through using maleimide-cysteine
reaction chemistry, as outlined above. Complexes 1 and 2 were incorporated into
TMR-tagged Nanodiscs according to Figure 6.2. Specifically, MSP was labeled with TMR
at Cys73. The tagged MSP was combined with a cholate-solubilized solution of DMPC
phospholipids and either complex 1 or 2 at molar ratios of 1:(90-X):180:X
(MSP:lipid:cholate:amount of 1 or 2). The cholate was removed with XAD-2 hydrophobic
beads and the resulting Nanodiscs were purified on an SEC column calibrated using a
standard mixture of four proteins - Bovine Serum Albumin (BSA), Bovine Liver Catalase,
Ferritin, and Thyroglobulin - with hydrodynamic radii in the range of interest. Based on
the calibration, the retention time for Nanodiscs with a diameter of 10 nm is between
bovine liver catalase and BSA.
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The maximum loading of complexes 1 and 2 into Nanodiscs was determined by
assembling particles with varied molar ratios of 1 and 2. For both constructs, a maximum
of 30% contrast agent loading relative to total lipid content (i.e., phospholipids + 1 or 2)
was achieved. Consequently, the loading percentages correspond to 137 ± 14 Gd(III) ions
per Nanodisc for multimeric Nanodiscs and 48 ± 8 for monomeric Nanodiscs. These values
represent an increase in Gd(III) loading on lipid-based particles with similarly sized HDL
particles achieving only 22 Gd(III)/particle.[163] T1 relaxivity was determined at low (1.41
T) and high (7 T) magnetic field strengths. Both multimeric Nanodiscs and monomeric
Nanodiscs have relaxivities of 17 mM−1 s−1 at 1.41 T (37 ◦C), which is comparable to
other lipid-based particles that typically report a relaxivity of 10-30 mM−1 s−1.[164]
Relaxivities at 7 T (25 ◦C) are 3.1 mM−1 s−1 ± 0.1 for multimeric Nanodiscs and 4.2
mM−1 s−1 ± 0.2 for monomeric Nanodiscs. Additionally, the stability and shelf life
Nanodiscs was explored. Nanodiscs were determined to be stable for at least 2 weeks in
buffer and at least 1 week in cell media at a temperature of 4 ◦C.
6.3.2 Labeling of Cells using Gd(III) Nanodiscs
The ability of both varieties of Nanodiscs to label cells was investigated with HeLa and
MCF7 cells. All experiments were performed with a 24 h incubation time at concentrations
that maintained ≥90% cell viability. Confocal laser scanning microscopy was used to
determine cellular localization of TMR-tagged MSP. Microscopy images showed
intracellular accumulation of the Nanodiscs (Figure 6.3). The localization of contrast
agent-doped Nanodiscs was compared to that of Nanodisc controls without Gd(III)
contrast agent. From these images, it does not appear that incorporation of complexes 1
and 2 into Nanodiscs significantly affects intracellular accumulation. As complexes 1 and 2
are not covalently attached to the TMR-tagged MSP, the localization of these contrast
agents was determined using cell fractionation. Briefly, the membrane and cytosol of the
cells were separated and analyzed for Gd(III) content by ICP-MS. These data show that
both multimeric and monomeric Nanodiscs show approximately 7-fold greater
accumulation in the membrane compared to the cytosol. (Figure 6.4) This suggests that
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the lipids and the contrast agents in the Nanodiscs can freely exchange with the lipids
present in the cell membrane.
The enhanced cellular retention of multimeric Nanodiscs in both cell lines (Figure 6.5)
suggests that these Nanodiscs may be used for cell tracking applications where it is critical
that contrast agents remain associated with cells for longer periods of time. Examples of
such applications include fate-mapping transplanted stem cells and monitoring
developmental events. The lower retention of monomeric Nanodiscs indicates that these
Nanodiscs are better suited for applications where clearance of the contrast agent is desired
such as detection of cancer and disease markers. Therefore, the Nanodiscs can be tailored
to specific imaging applications by altering the lipophilic contrast agent incorporated into
the particles. This attribute further shows the modularity of the Nanodiscs and provides
opportunities for further research. Additionally, Nanodiscs are not limited by type of
phospholipid used, allowing for a rational design approach, using lipids with shorter or
longer tails, based on the imaging application desired.
6.3.3 Magnetic Resonance Imaging
To investigate the ability of Nanodiscs to enhance T1-weighted contrast of cell populations,
MR images of HeLa cell pellets were acquired at 7 T (Figure 6.7). Cells were labeled with
Nanodiscs containing no agent (0.6 µM), multimeric Nanodiscs (0.2 M, 30 µM Gd(III)),
monomeric Nanodiscs (0.6 µM, 30 µM Gd(III)), and clinically approved ProHance (30
µM). The most significant contrast enhancement was observed in cells treated with
monomeric Nanodiscs showing a 66% reduction of T1 compared to untreated cells. Cells
labeled with the multimeric Nanodiscs showed a 25% reduction. As expected, no
significant contrast enhancement was observed with cells treated with Nanodiscs
containing no agent or ProHance. These results are consistent with the cell labeling trends
observed in Figure 6.6. Overall, these results show that monomeric Nanodiscs are a viable
and promising option for labeling cells for use in cell imaging.
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6.4 Conclusions
Multimeric and monomeric lipophilic MR contrast agents were incorporated into
TMR-tagged Nanodiscs to generate bimodal agents for cellular imaging. Multimeric
Nanodsics achieved 3-fold higher Gd(III)/Nanodisc loading than those containing
monomeric agents. Despite the higher concentration of Gd(III)/Nanodisc, multimeric
Nanodiscs did not label cells as effectively as monomeric Nanodiscs. Cellular retention
studies showed that 50% or greater of the initial multimeric agent remained associated
with cells for 72 h, whereas the monomeric agent leached from cells at a much faster rate.
This indicates that multimeric Nanodiscs may be useful for long-term cell tracking studies
while monomeric Nanodiscs are more appropriate for applications that require the rapid
clearance of the contrast agent from cells. These results suggest that the Nanodisc system
can be tailored for the specific needs of the study or application. Additionally, this work
showed that monomeric Nanodiscs produced significant contrast enhancement of cell
populations at 7 T suggesting that these Nanodiscs may be useful for in vivo applications.
Using Nanodiscs as therapeutic delivery agents is a concept that is just beginning to be
explored. Previous work using Nanodiscs as delivery agents focused on using therapeutic
lipids.[45] This work shows that Nanodiscs can be used as delivery agents for imaging
applications as well, utilizing a bimodal imaging platform of both MRI and optical
fluorescence. This work illustrates that Nanodiscs are capable of delivering lipophilic
compounds into cell membranes more efficiently than detergent-based systems. Nanodiscs
have the additional advantages over current delivery systems employing liposomes of
stoichiometric control and longer shelf life. The Nanodisc delivery agents can further be
tailored by varying the type of lipids being used or employing different labels on the MSP,
whether they are fluorophores or a targeting moieties. These advantages open up the field
of therapeutic and imaging delivery agents with a vast set of possibilities to be explored.
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6.5 Figures and Tables
Figure 6.1: Structures of lipophilic contrast agents for incorporation into nanodiscs.
Complex 1 is multimeric and contains three Gd(III) chelates, while 2 is monomeric and
contains a single Gd(III) chelate.
Figure 6.2: A diagram showing the basic procedure of assembling and purifying Nanodiscs
with the Gd(III) chelate.
85
Figure 6.3: Confocal micrographs of HeLa cells incubated with 1 µM of empty, multimeric,
and monomeric Nanodiscs show intracellular accumulation. Blue = DAPI, Red = TMR.
Scale bar = 20 µm.
Figure 6.4: Fractionation data showing that contrast agent accumulated more in the cell
membrane as opposed to the cytosolic fraction. This data suggests that an exchange
between lipids and contrast agents happens between Nanodiscs and cell membrane
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Figure 6.5: Cellular proliferation and retention of HeLa and MCF7 cells treated with
concentrations of multimeric (45 µM Gd(III)), monomeric (25 µM Gd(III)), and ProHance
(2 mM) chosen to equalize cell labeling. (A) Cellular proliferation was measured as the fold
increase in cell number between time = 0 and 72 h. No significant change in proliferation
was observed. (B) Cellular retention in HeLa cells was determined by measuring the
Gd(III) content in the media at 4, 24, 48, and 72 h after labeling. Multimeric Nanodiscs
show the greatest retention in HeLa cells. (C) Cellular retention was also determined in
MCF7 cells. Similar retention was observed for multimeric Nanodiscs and ProHance while
monomeric Nanodiscs were retained least effectively by cells. Error bars represent the
standard deviation of triplicate experiments.
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Figure 6.6: Cell uptake of multimeric and monomeric Nanodiscs was determined in HeLa
(red) and MCF7 (blue) cells at varied incubation concentrations. (A) Uptake at variable
Nanodisc incubation concentrations shows the same labeling for multimeric and monomeric
Nanodiscs. (B) Uptake at variable Gd(III) incubation concentrations shows that
monomeric Nanodiscs attains higher cell labeling. Error bars represent the standard
deviation of triplicate experiments.
Figure 6.7: T1-weighted cell pellet images of HeLa cells incubated with empty Nanodiscs,
multimeric Nanodiscs, monomeric Nanodiscs, and Prohance acquired at 7 T. TE = 11 ms,
TR = 500 ms, MTX = 256 x 256, and slice thickness is 1.0 mm. Scale bar represents 1
mm. Error bars represent standard deviation of the mean of 4 slices. These images show
that at incubation concentrations of 30 µM Gd(III), monomeric Nanodiscs produce the
greatest image contrast.
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CHAPTER 7
CONCLUSIONS AND FUTURE WORKS
This work examines and describes the benefits and applications of using Nanodiscs in the
study of membrane interactions. Events involving the membrane, and specifically
membrane proteins, play a central role in biochemistry and pharmacology, therefore a
deeper understanding of the mechanisms behind these events is crucial for the
advancements of these fields. Previous efforts in the study of membrane proteins have
encountered challenges when it comes to considering all the variables of solibilizing
membrane proteins. Nanodiscs, however, have provided a monodisperse platform for the
solubilization of membrane proteins that offers a native lipid bilayer, unparalleled
stoichiometric control, and is extremely modular with the ability to be tailored to specific
needs. Details have been provided throughout the previous chapters that describe the
development of analytical systems employing Nanodiscs as well as the development of
systems that can be further combined with Nanodiscs for the biophysical characterization
of membrane-specific events.
The development and use of a linear dichroism instrument in order to calculate the
orientation of heme-containing CYP’s incorporated in Nanodiscs was described in Chapter
2. The work takes advantage of the ability of Nanodiscs to lay flat on silicon surfaces, as
has been shown in previous studies.[30] Nanodiscs further allow for the incorporation of
membrane proteins in a native-like lipid bilayer environment, preserving the activity and
natural conformation of the protein. Combining Nanodiscs with LD spectroscopy allowed
for the determination of the orientation of three different CYP enzymes within a POPC
lipid bilayer. The experimental work was complemented by MD simulations that showed
the structure and orientation in detail.
While the orientation of the enzymes within the lipid bilayer is an important step into
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further understanding the mechanism of substrate recruitment, there are other biologically
relevant factors that should also be considered. Lipid composition is usually a variable that
is simplified in structural studies, often employing the use of only one lipid, while cellular
membranes are often complicated and are composed of multiple lipid species.[165] Because
of the specific interactions between the globular domain of the protein and the lipid head
groups, an exploration into the effect of differently charged lipid species on the orientation
of these enzymes would lead to a better understanding of the topology of the protein.
Nanodiscs are especially amenable to such studies because of the ease of control over lipid
composition. Additionally, CYP17 has been known to go through conformational and
activity changes due to interactions with Cytochrome b5.[166, 167] These studies would
imply that CYP’s can experience a change in orientation based on their interactions with
redox partners. Studies of multiple-protein systems are warranted and feasible using the
Nanodisc platform.
Nanodiscs can further be used in biophysical characterization of molecular recognition
events as probed hydrostatic pressure in a system similar to that described in Chapter 3.
In that chapter, a method to study the refractive index change based on increasing
hydrostatic pressure was developed. The instrument was validated and calibrated using
solutions of known refractive indices at atmospheric pressure prior to observing changes
under pressure. The system is well suited for probing biomolecular interactions under
pressure primarily because the BIND Assay chips are used and specialized optics or
geometries are not required, unlike SPR.[108] The system can be further utilized in the
study of molecular recognition events. Hydrostatic pressure has been previously used to
study protein-protein and protein-nucleic acid interactions.[110, 168, 169] Using the current
instrument and method, it is possible to employ Nanodiscs in the study of protein-lipid
interactions. Tavoosi and coworkers showed that Factor VII gets activated through the
GLA domain in a Ca2+ dependent fashion.[170] Using this method, it would be possible to
elucidate the mechanism behind this activation and its dependence on Ca2+. In order to
further explore the lipid-membrane interactions present in the blood coagulation cascade in
a high-throughput fashion a lipid assay with individually addressable sensors was designed.
Chapter 4 describes the development of methods for creating robust, multiplexed arrays of
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Nanodiscs on the basis of DNA-encoding. Nanodiscs were chemically labeled with ssDNA
by utilizing the single cysteine mutant scaffold protein, MSP1D1 D73. The resulting
Nanodisc arrays were thoroughly characterized and shown to exhibit specific binding
through DNA base pair recognition. Furthermore, the utility of these arrays was
demonstrated by monitoring the binding of annexin to POPS phospholipids. To further
expand the utility and application of this assay, it will be applied to the study of
protein-protein and protein-membrane interactions in the blood coagulation cascade.
Factor VII is known to be activated by both anionic phospholipids as well as the enzyme
cofactor Tissue Factor. However, details behind the activation mechanism are not known
and they need to be unraveled. Using the combination of Nanodiscs with photonic
microring resonators, it is indeed possible to easily create a highly multiplex-able assay
with multiple lipid compositions and multiple Tissue Factor concentrations on the same
sensor chip. Going beyond the study of the mechanism behind blood coagulation, this
platform presents a powerful approach for highly multiplexed studies of biomolecular
interactions occurring at the membrane surface.
To further increase the speed and reduce sample requirements of biomolecular assays
involving Nanodiscs, a modular platform for the handling of small volumes has been
developed. Chapter 5 describes the implementation and optimization of a microfluidic
device for the assembly of Nanodiscs. This device is capable of assembling Nanodiscs in a
matter of minutes, while using microliter volumes of reagents. The initial validation and
proof of the device was established by assembling ”empty” Nanodiscs, which did not have
a target membrane protein incorporated. The work then focused on incorporating
CYP3A4 in order to show that the device could be used to optimize volumes and ratios of
lipids, target protein, and scaffold protein, as well as showing that detergent screens were
possible on the device. The microfluidic platform employed a gradient of lipid:MSP:target
ratios for the optimization of starting materials, utilizing small volumes of protein. Further
development of this platform will explore incorporating membrane protein targets which
have yet to be inserted into Nanodiscs. Furthermore, the microfluidic device is modular
and this advantage can be leveraged to include multiple steps of purification, including
affinity and size purification. This method has the potential not only to decrease the cost
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of optimizing target protein incorporation, but also presents an opportunity for the
development of therapeutic and diagnostic Nanodiscs.
Nanodiscs have previously been used to deliver therapeutic phospholipids to treat RSV.
Within this work, Nanodiscs were used to deliver imaging agents and provide a means for
cell tracking, as described in Chapter 6. Nanodiscs were labeled with a fluorophore, using
maleimide-cysteine chemistry on the cysteine mutant of the scaffold protein, and an MRI
contrast agent was incorporated into the bilayer. This construct, when used for the
incubation of cells, produced a contrast higher than clinically available agents and was
validated in two different cell lines. Since the construct did not include any targeting
moieties, a step forward would be to use a targeting molecule in order to selectively label
cells. Nanodiscs present a very modular platform, having the ability to use single point
mutations within the membrane protein to introduce reactive residues for the chemical
attachment of molecules of interest. Taking advantage of this idea, it is possible to
introduce a targeting label, such as cyclo(RGD) in order to target over-expressed integrins
on certain cancer cell lines. This would provide a platform for the enhanced labeling of
cancer cells, as well as the potential for the selective delivery of therapeutic compounds.
Furthermore, efforts have gone into combining delivery agents with microfluidic
approaches[171], a concept which can be implemented with Nanodisc microfluidic
approaches.
Nanodiscs are emerging as a key tool in biochemical and biophysical research studies.
The possess critical advantages over similar solubilization systems and present the
potential to be integrated with multiple analytical systems, including spectroscopic
methods, biosensors, and even mass spectrometry. Furthermore, Nanodiscs are just
beginning to be utilized as therapeutic and imaging compound delivery agents - an area
which has a lot of room for expansion and research. Additionally, the development of
Nanodisc-solubilized membrane protein libraries has recently been accomplished[172, 173]
and has opened the door to new and innovative techniques within biochemical and
pharmaceutical research. The innovations and applications of Nanodiscs present the
opportunity for great expansion within the bio-analytical field of research.
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